Your browser is no longer supported. Please, upgrade your browser.
Settings
EXEL Exelixis, Inc. daily Stock Chart
EXEL [NASD]
Exelixis, Inc.
Index- P/E26.38 EPS (ttm)0.81 Insider Own1.50% Shs Outstand293.47M Perf Week-0.05%
Market Cap6.26B Forward P/E19.09 EPS next Y1.12 Insider Trans-16.17% Shs Float286.61M Perf Month8.66%
Income253.40M PEG0.76 EPS next Q0.16 Inst Own79.60% Short Float5.10% Perf Quarter-1.52%
Sales583.90M P/S10.73 EPS this Y276.40% Inst Trans0.03% Short Ratio3.23 Perf Half Y-28.03%
Book/sh2.26 P/B9.44 EPS next Y29.85% ROA39.60% Target Price33.17 Perf Year-18.58%
Cash/sh1.46 P/C14.65 EPS next 5Y34.50% ROE75.50% 52W Range18.50 - 32.50 Perf YTD-29.80%
Dividend- P/FCF43.10 EPS past 5Y20.50% ROI55.40% 52W High-34.34% Beta2.06
Dividend %- Quick Ratio6.60 Sales past 5Y57.00% Gross Margin97.00% 52W Low15.35% ATR0.72
Employees372 Current Ratio6.70 Sales Q/Q162.40% Oper. Margin44.30% RSI (14)53.23 Volatility3.24% 3.48%
OptionableYes Debt/Eq0.00 EPS Q/Q584.60% Profit Margin43.40% Rel Volume0.60 Prev Close21.07
ShortableYes LT Debt/Eq0.00 EarningsAug 01 AMC Payout0.00% Avg Volume4.53M Price21.34
Recom1.90 SMA201.85% SMA503.33% SMA200-13.75% Volume2,731,045 Change1.28%
May-11-18Reiterated Needham Buy $33 → $30
Oct-17-17Reiterated RBC Capital Mkts Outperform $33 → $39
Oct-17-17Reiterated Needham Buy $30 → $33
Oct-16-17Reiterated SunTrust Buy $32 → $35
Sep-22-17Downgrade Leerink Partners Outperform → Mkt Perform
Sep-15-17Initiated RBC Capital Mkts Outperform $32
Sep-12-17Reiterated Needham Buy $28 → $30
Jul-14-17Initiated SunTrust Buy $33
Mar-31-17Initiated Needham Buy $28
Mar-16-17Initiated Oppenheimer Perform
Feb-28-17Downgrade Stifel Buy → Hold $21 → $22
Nov-03-16Initiated Deutsche Bank Buy $17
Oct-10-16Upgrade Piper Jaffray Neutral → Overweight
Sep-15-16Reiterated Stifel Buy $12 → $15
Aug-04-16Reiterated Stifel Buy $10 → $12
Jun-21-16Reiterated Leerink Partners Outperform $8 → $10
Apr-26-16Reiterated Stifel Buy $7 → $8
Apr-04-16Upgrade Stifel Hold → Buy $7
Jan-19-16Upgrade Leerink Partners Mkt Perform → Outperform
Sep-02-14Downgrade Stifel Buy → Hold
Jul-17-18 04:05PM  Exelixis to Release Second Quarter 2018 Financial Results on Wednesday, August 1, 2018 Business Wire
Jul-11-18 07:05PM  Top 5 Biotech Stocks for 2018 Investopedia
Jul-04-18 05:00PM  Exelixis Announces CELESTIAL Phase 3 Pivotal Trial Results Published in The New England Journal of Medicine Business Wire
Jun-28-18 08:51AM  3 Top Healthcare Stocks to Buy Right Now Motley Fool
Jun-27-18 08:42AM  Exelixis (EXEL) Jumps: Stock Rises 8% Zacks
08:00AM  Exelixis to Be Added to the S&P MidCap 400 Index Business Wire
Jun-26-18 08:34AM  Benzinga's Daily Biotech Pulse: Epidiolex, Roche's Influenza Drug Gets Priority Review Status, Xeris Jumps On Positive Trial Results Benzinga +7.98%
08:05AM  Better Buy: Exelixis, Inc. vs. Immunogen, Inc. Motley Fool
08:00AM  Today's Research Reports on Trending Tickers: Exelixis and Zafgen ACCESSWIRE
Jun-25-18 06:23PM  Copart Set to Join S&P 500; Exelixis to Join S&P MidCap 400; Clarifications to S&P U.S. Indices Methodology PR Newswire
Jun-21-18 08:25AM  Today's Research Reports on Trending Tickers: bluebird bio and Exelixis ACCESSWIRE
07:30AM  Exelixis Inc (NASDAQ:EXEL) Has Attractive Fundamentals, Heres Why Simply Wall St.
07:25AM  Stock Performance Review on Exelixis and Three Other Biotech Stocks ACCESSWIRE
Jun-19-18 07:05PM  Cramer's lightning round: GE's CEO was dealt 'one of the ... CNBC Videos
06:50PM  Cramer's lightning round: GE's CEO was dealt 'one of the worst hands that anyones ever been given' CNBC
01:41PM  Why I Like Exelixis Inc (NASDAQ:EXEL) Simply Wall St.
Jun-14-18 08:10AM  Consolidated Research: 2018 Summary Expectations for Rayonier Advanced Materials, CYS Investments, Avid Bioservices, American Airlines Group, Exelixis, and International Business Machines Fundamental Analysis, Key Performance Indications GlobeNewswire
Jun-05-18 04:05PM  Exelixis to Present at the William Blair & Co. 38th Annual Growth Stock Conference on June 12, 2018 Business Wire
Jun-04-18 08:20AM  Today's Research Reports on Trending Tickers: Exelixis and Celgene ACCESSWIRE
Jun-03-18 09:00AM  Exelixis Announces Results from Sub-Group Analyses of the Phase 3 Pivotal CELESTIAL Trial of Cabozantinib for Advanced Hepatocellular Carcinoma Presented at ASCO 2018 Business Wire
Jun-01-18 02:42PM  Intrinsic Calculation For Exelixis Inc (NASDAQ:EXEL) Shows Investors Are Overpaying Simply Wall St.
08:00AM  Exelixis Announces Further Expansion to Clinical Research Protocol for Phase 1b COSMIC-021 Trial of Cabozantinib in Combination with Anti-PD-L1 Immunotherapy in Patients with Locally Advanced or Metastatic Solid Tumors Business Wire
May-30-18 08:14AM  Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA Benzinga
May-29-18 04:05PM  Exelixis Announces U.S. FDA Accepts Supplemental New Drug Application for CABOMETYX® (cabozantinib) in Previously Treated Advanced Hepatocellular Carcinoma Business Wire
May-26-18 11:07AM  The Week Ahead In Biotech: ASCO Presentations In The Spotlight Benzinga
May-23-18 02:29PM  Biotech Stock Roundup: FDA Gives Nod to Amgen's Drugs, EU Approves Exelixis' Cabometyx Zacks
08:00AM  Today's Research Reports on Trending Tickers: Tesaro and Exelixis ACCESSWIRE
May-22-18 04:15PM  Exelixis Appoints Andrew R. Peters to Newly Created Position of Vice President, Strategy Business Wire
May-21-18 07:10AM  Wired News EU Approved Exelixis/Ipsens CABOMETYX in Europe for Intermediate - or Poor-Risk Advanced Renal Cell Carcinoma ACCESSWIRE
May-19-18 09:12AM  3 Top Biotech Stocks to Buy Right Now Motley Fool
May-17-18 09:35AM  Exelixis' Cabometyx Gets EU Nod for First-Line Kidney Cancer Zacks +5.63%
08:27AM  Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More Benzinga
01:01AM  Exelixis Partner Ipsen Announces European Commission Approval of CABOMETYX® (Cabozantinib) for Previously Untreated Intermediate- or Poor-Risk Advanced Renal Cell Carcinoma Business Wire
May-16-18 08:40AM  Are Options Traders Betting on a Big Move in Exelixis (EXEL) Stock? Zacks
May-11-18 06:58PM  Trump Announces Plan to Reign In Drug Prices and Pharma Stocks Rally. Zacks +5.33%
09:30AM  Exelixis, Applied Optoelectronics and Nvidia as Zacks Bull and Bear of the Day Zacks
08:39AM  Zacks.com featured highlights include: Marine Products, Nutrisystem, Exelixis, Illumina and Baxter Zacks
08:39AM  Array BioPharma (ARRY) in Focus: Stock Moves 5.5% Higher Zacks
08:16AM  3 Healthcare Stocks Growing Over 100% Motley Fool
06:00AM  Bull of the Day: Exelixis (EXEL) Zacks
May-10-18 05:00PM  This Biotech Stock Crashed On Colon Cancer Flop With Roche Investor's Business Daily -14.43%
04:32PM  Why Booking Holdings, Exelixis, and L Brands Slumped Today Motley Fool
03:33PM  Hospital Product Sales Drive Mallinckrodt (MNK) Q1 Earnings Zacks
03:03PM  Why Exelixis Dropped Today Motley Fool
08:47AM  5 Winning Stocks With Superb Efficiency Level Zacks
01:01AM  Exelixis Provides Update on IMblaze370 Phase 3 Pivotal Trial of Atezolizumab and Cobimetinib in Patients With Heavily Pretreated Locally Advanced or Metastatic Colorectal Cancer Business Wire
May-09-18 08:47AM  Prothena (PRTA) Q1 Loss Wider Than Expected, Sales Miss Zacks
May-08-18 04:05PM  Exelixis to Present at the Bank of America Merrill Lynch Health Care Conference on May 15, 2018 Business Wire
09:59AM  Intercept (ICPT) Q1 Loss Narrower Than Expected, Sales Lag Zacks
May-07-18 11:45AM  Edited Transcript of EXEL earnings conference call or presentation 2-May-18 9:00pm GMT Thomson Reuters StreetEvents
May-04-18 04:06PM  Exelixis Reaccelerates Growth Motley Fool
May-03-18 07:03PM  Cramer's lightning round: Don't buy Monster Beverageit's... CNBC Videos +7.76%
06:49PM  Cramer's lightning round: Don't buy Monster Beverageit's running out of steam CNBC
02:55PM  Exelixis (EXEL) Q1 2018 Earnings Conference Call Transcript Motley Fool
08:32AM  Exelixis (EXEL) Q1 Earnings & Sales Top on Cabometyx Strength Zacks
08:31AM  Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss Benzinga
May-02-18 07:46PM  Exelixis: 1Q Earnings Snapshot Associated Press
05:01PM  Exelixis Jumps After Demolishing First-Quarter Sales, Income Views Investor's Business Daily
04:06PM  Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer Business Wire
04:05PM  Exelixis Announces First Quarter 2018 Financial Results and Provides Corporate Update Business Wire
Apr-30-18 11:05AM  Is a Beat in the Cards for Exelixis (EXEL) in Q1 Earnings? Zacks
Apr-26-18 08:00AM  Cabozantinib to Be Featured in 15 Presentations at ASCO 2018 Annual Meeting Business Wire
Apr-18-18 02:00PM  Why Big Biotech Stocks May Get An Earnings Boost Investopedia
Apr-17-18 07:50AM  New Research Coverage Highlights Exelixis, Verizon Communications, AT&T, Snap, Allergan plc, and QUALCOMM Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire +6.23%
Apr-12-18 06:00AM  Why Exelixis' Stock Broke Down in March Motley Fool
Apr-11-18 04:05PM  Exelixis to Release First Quarter 2018 Financial Results on Wednesday, May 2, 2018 Business Wire
08:52AM  Exelixis (EXEL) in Focus: Stock Moves 7.7% Higher Zacks
Apr-10-18 04:13PM  Exelixis Rebounds As Analyst Urges Investors To Buy Monday's Dip Investor's Business Daily +7.68%
08:20AM  Todays Research Reports on Trending Tickers: Exact Sciences and Exelixis ACCESSWIRE
Apr-09-18 04:05PM  Exelixis Elects Dr. Maria Freire to Its Board of Directors Business Wire -6.73%
Apr-06-18 10:03AM  Moving Average Crossover Alert: Exelixis, Inc. (EXEL) Zacks
Apr-05-18 08:30AM  Todays Research Reports on Trending Tickers: Exelixis and Galectin Therapeutics ACCESSWIRE
Apr-04-18 09:15PM  3 Top Biotech Stocks to Buy in April Motley Fool
04:32PM  Why Exelixis Will Triumph In Liver Cancer Battle With Eli Lilly Investor's Business Daily
08:34AM  Weakness Seen in Exelixis (EXEL) Estimates: Should You Stay Away? Zacks
Apr-02-18 07:40AM  Wired News Exelixis Partner Ipsen Gets EMA Validation of the Application for a New Indication for CABOMETYX ACCESSWIRE
Mar-29-18 08:20AM  Todays Research Reports on Trending Tickers: Exelixis and Sarepta Therapeutics ACCESSWIRE
Mar-28-18 09:31AM  Why Is Exelixis (EXEL) Down 17.2% Since Its Last Earnings Report? Zacks
01:05AM  Exelixis Partner Ipsen Announces EMA Validation of the Application for a New Indication for CABOMETYX® (cabozantinib) for Previously Treated Advanced Hepatocellular Carcinoma Business Wire
Mar-26-18 09:45AM  Exelixis Cabometyx Gets Positive CHMP Opinion in Europe Zacks
Mar-23-18 02:05AM  Exelixis Partner Ipsen Announces Positive CHMP Opinion for CABOMETYX® (cabozantinib) for Previously Untreated Intermediate- or Poor-Risk Advanced Renal Cell Carcinoma Business Wire
Mar-15-18 08:00AM  Exelixis Submits U.S. Supplemental New Drug Application for CABOMETYX® (Cabozantinib) for Previously Treated Advanced Hepatocellular Carcinoma Business Wire
Mar-13-18 11:29AM  Why Exelixis Fell 14.9% in February Motley Fool
Mar-09-18 07:55AM  Edited Transcript of EXEL earnings conference call or presentation 26-Feb-18 10:00pm GMT Thomson Reuters StreetEvents
Mar-06-18 04:05PM  Exelixis Announces Webcasts of Investor Conference Presentations in March Business Wire
Feb-28-18 02:26PM  5 Biotech Stocks to Sell Amid the Latest Slaughter InvestorPlace
Feb-27-18 04:27PM  These Biotechs Diverge After Biggest Moneymakers Lag Expectations Investor's Business Daily -8.20%
04:09PM  Exelixis in Transition Motley Fool
03:49PM  Exelixis (EXEL) Q4 Earnings Meet Estimates, Revenues Beat (revised) Zacks
09:53AM  Perrigo (PRGO) Postpones Q4 Earnings Results, Shares Down Zacks
09:16AM  Exelixis (EXEL) Q4 Earnings Meet Estimates, Revenues Beat Zacks
Feb-26-18 09:56PM  Exelixis Inc. (EXEL) Q4 2017 Earnings Conference Call Transcript Motley Fool
08:00PM  Exelixis Announces Collaborator Daiichi Sankyos Submission of Regulatory Filing for Esaxerenone (CS-3150) in Japan Business Wire
05:12PM  Exelixis meets 4Q profit forecasts Associated Press
04:58PM  Cancer Biotech Plunges Despite Narrowly Beating Quarterly Sales Views Investor's Business Daily
04:05PM  Exelixis Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Business Wire
01:15PM  Exelixis, Inc. to Host Earnings Call ACCESSWIRE
11:14AM  Exelixis Q4 Earnings Outlook Benzinga
10:03AM  Does Exelixis Incs (NASDAQ:EXEL) PE Ratio Warrant A Sell? Simply Wall St.
Feb-23-18 09:19AM  Achillion (ACHN) Q4 Loss Widens, Plans Job Cuts to Save Cost Zacks
Exelixis, Inc., a biotechnology company, engages in the discovery, development, and commercialization of new medicines to enhance care and outcomes for people with cancer. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. It also offers COTELLIC tablets, an inhibitor of MEK in combination with vemurafenib for the treatment of patients with BRAF V600E or V600K mutation-positive advanced melanoma in the United States; and in combination with vemurafenib in other territories, including the European Union, Switzerland, Canada, Australia, and Brazil. Exelixis, Inc. has collaboration and license agreement with Ipsen Pharma SAS, Genentech, Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Sanofi, Merck, Daiichi Sankyo Company Limited, and Invenra, Inc. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MORRISSEY MICHAELPresident and CEOJul 16Option Exercise5.5090,000495,000215,000Jul 17 08:19 PM
MORRISSEY MICHAELPresident and CEOJul 16Sale21.1390,0001,901,700125,000Jul 17 08:19 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOJul 02Option Exercise5.5022,500123,750300,788Jul 03 09:07 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOJul 02Sale21.2022,500477,000278,288Jul 03 09:07 PM
MORRISSEY MICHAELPresident and CEOJun 25Option Exercise5.5090,000495,000215,000Jun 27 08:12 PM
MORRISSEY MICHAELPresident and CEOJun 25Sale19.6290,0001,765,800125,000Jun 27 08:12 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOJun 01Option Exercise5.5022,500123,750300,788Jun 01 07:58 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOJun 01Sale20.8022,500468,000278,288Jun 01 07:58 PM
Hessekiel JeffreyEVP and General CounselMay 31Sale20.7165,0001,346,150254,450Jun 01 08:00 PM
FELDBAUM CARL BDirectorMay 30Option Exercise4.2614,75062,79549,483Jun 01 07:59 PM
FELDBAUM CARL BDirectorMay 30Sale20.6034,262705,79715,221Jun 01 07:59 PM
MORRISSEY MICHAELPresident and CEOMay 24Option Exercise5.5090,000495,000215,000May 24 08:16 PM
MORRISSEY MICHAELPresident and CEOMay 24Sale20.5590,0001,849,500125,000May 24 08:16 PM
WILLSEY LANCEDirectorMay 22Sale21.4050,0001,070,000418,273May 24 08:24 PM
Haley Patrick J.Sr. Vice President, CommercialMay 18Sale21.613,66379,157127,278May 18 08:02 PM
SCANGOS GEORGE ADirectorMay 15Option Exercise11.6615,000174,9001,478,648May 16 07:59 PM
MARCHESI VINCENT TDirectorMay 11Option Exercise11.6615,000174,900140,913May 11 07:58 PM
MARCHESI VINCENT TDirectorMay 11Sale19.0315,000285,450125,913May 11 07:58 PM
COHEN CHARLESDirectorMay 09Option Exercise11.6615,000174,900263,180May 10 08:03 PM
COHEN CHARLESDirectorMay 09Sale21.4215,000321,300248,180May 10 08:03 PM
Haley Patrick J.Sr. Vice President, CommercialMay 07Option Exercise1.9015,00028,500145,941May 07 08:06 PM
PAPADOPOULOS STELIOSDirectorMay 07Option Exercise11.6615,000174,9001,049,314May 07 08:07 PM
PAPADOPOULOS STELIOSDirectorMay 07Sale22.1515,000332,2501,034,314May 07 08:07 PM
Haley Patrick J.Sr. Vice President, CommercialMay 07Sale22.0015,000330,000130,941May 07 08:06 PM
Haley Patrick J.Sr. Vice President, CommercialMay 04Option Exercise1.9010,00019,000143,490May 07 08:06 PM
Hessekiel JeffreyEVP and General CounselMay 04Sale22.3620,000447,200319,450May 07 08:07 PM
Haley Patrick J.Sr. Vice President, CommercialMay 04Sale22.3812,549280,847130,941May 07 08:06 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOMay 03Option Exercise5.5022,500123,750300,788May 04 07:06 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOMay 03Sale23.0922,500519,417278,288May 04 07:06 PM
Hessekiel JeffreyEVP and General CounselApr 27Option Exercise1.7025,00042,500339,450Apr 30 08:23 PM
Haley Patrick J.Sr. Vice President, CommercialApr 24Option Exercise1.7020,00034,000133,490Apr 26 08:22 PM
Garber Alan MDirectorApr 16Option Exercise11.6615,000174,90076,329Apr 18 08:11 PM
WYSZOMIERSKI JACK LDirectorApr 16Option Exercise9.8230,000294,450108,803Apr 18 08:12 PM
Garber Alan MDirectorApr 16Sale20.2515,000303,75061,329Apr 18 08:11 PM
WYSZOMIERSKI JACK LDirectorApr 16Sale20.2514,959302,92093,844Apr 18 08:12 PM
MORRISSEY MICHAELPresident and CEOApr 11Option Exercise5.5090,000495,000221,653Apr 13 08:09 PM
MORRISSEY MICHAELPresident and CEOApr 11Sale20.7890,0001,870,200131,653Apr 13 08:09 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOApr 06Option Exercise7.1814,591104,763277,280Apr 06 07:48 PM
MARCHESI VINCENT TDirectorMar 06Option Exercise7.9715,000119,550140,913Mar 07 07:23 PM
MARCHESI VINCENT TDirectorMar 06Sale24.7315,000370,950125,913Mar 07 07:23 PM
COHEN CHARLESDirectorMar 05Option Exercise7.9715,000119,550263,180Mar 07 07:25 PM
FELDBAUM CARL BDirectorMar 05Option Exercise11.6611,000128,26045,733Mar 07 07:26 PM
FELDBAUM CARL BDirectorMar 05Sale23.8811,000262,68034,733Mar 07 07:26 PM
COHEN CHARLESDirectorMar 05Sale24.2315,000363,450248,180Mar 07 07:25 PM
WILLSEY LANCEDirectorMar 02Option Exercise9.8230,000294,450498,273Mar 02 08:01 PM
PAPADOPOULOS STELIOSDirectorMar 02Option Exercise7.9715,000119,5501,049,314Mar 02 08:03 PM
PAPADOPOULOS STELIOSDirectorMar 02Sale24.0515,000360,7501,034,314Mar 02 08:03 PM
WILLSEY LANCEDirectorMar 02Sale23.9130,000717,300468,273Mar 02 08:01 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOMar 01Option Exercise4.427,29332,235262,689Mar 02 08:04 PM
POSTE GEORGEDirectorFeb 28Option Exercise11.6615,000174,90098,398Mar 02 07:59 PM
Haley Patrick J.Sr. Vice President, CommercialFeb 28Option Exercise2.5813,62535,200158,519Mar 02 08:00 PM
Haley Patrick J.Sr. Vice President, CommercialFeb 28Sale27.1345,0291,221,637113,490Mar 02 08:00 PM
POSTE GEORGEDirectorFeb 28Sale26.2615,000393,90083,398Mar 02 07:59 PM
Garber Alan MDirectorJan 09Option Exercise7.9711,50091,65572,829Jan 10 07:27 PM
Garber Alan MDirectorJan 09Sale30.0011,500345,00061,329Jan 10 07:27 PM
Garber Alan MDirectorJan 08Option Exercise7.973,50027,89564,829Jan 10 07:27 PM
Garber Alan MDirectorJan 08Sale31.293,500109,51561,329Jan 10 07:27 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOSep 28Option Exercise9.9133,334330,340216,339Sep 28 07:45 PM
Hessekiel JeffreyEVP and General CounselSep 28Option Exercise1.9025,00047,500292,946Sep 28 07:47 PM
Hessekiel JeffreyEVP and General CounselSep 28Sale24.3225,000608,000267,946Sep 28 07:47 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOSep 28Sale23.7433,334791,349183,005Sep 28 07:45 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOSep 27Option Exercise9.9133,333330,330216,338Sep 28 07:45 PM
Hessekiel JeffreyEVP and General CounselSep 27Option Exercise1.902,3024,374270,248Sep 28 07:47 PM
Hessekiel JeffreyEVP and General CounselSep 27Sale23.902,30255,018267,946Sep 28 07:47 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOSep 27Sale23.9433,333797,992183,005Sep 28 07:45 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOSep 26Option Exercise9.9133,333330,330216,338Sep 28 07:45 PM
Schwab GiselaPres Prod Dev & Med Aff & CMOSep 26Sale23.6833,333789,325183,005Sep 28 07:45 PM
PAPADOPOULOS STELIOSDirectorSep 22Sale25.4010,000254,0000Sep 22 07:07 PM
PAPADOPOULOS STELIOSDirectorSep 19Sale27.63127,7903,530,8381,034,314Sep 20 06:48 PM
PAPADOPOULOS STELIOSDirectorSep 18Sale27.7672,2102,004,5501,162,104Sep 20 06:48 PM
MORRISSEY MICHAELPresident and CEOSep 14Option Exercise1.70100,000170,000160,000Sep 14 07:14 PM
Haley Patrick J.Sr. Vice President, CommercialSep 14Sale27.2160,6401,650,01441,553Sep 15 06:43 PM
MORRISSEY MICHAELPresident and CEOSep 14Sale27.08100,0002,708,00060,000Sep 14 07:14 PM
MORRISSEY MICHAELPresident and CEOSep 13Option Exercise1.70100,000170,000160,000Sep 14 07:14 PM
WILLSEY LANCEDirectorSep 13Sale26.9750,0001,348,500468,273Sep 14 07:18 PM
MORRISSEY MICHAELPresident and CEOSep 13Sale27.04100,0002,704,00060,000Sep 14 07:14 PM
MORRISSEY MICHAELPresident and CEOSep 12Option Exercise1.70100,000170,000160,000Sep 14 07:14 PM
Senner Christopher J.EVP and CFOSep 12Option Exercise3.66100,000366,000202,759Sep 14 07:17 PM
WILLSEY LANCEDirectorSep 12Sale26.7950,0001,339,500518,273Sep 14 07:18 PM
Senner Christopher J.EVP and CFOSep 12Sale26.79100,0002,679,000102,759Sep 14 07:17 PM
MORRISSEY MICHAELPresident and CEOSep 12Sale26.59100,0002,659,00060,000Sep 14 07:14 PM
CLVS Clovis Oncology, Inc. daily Stock Chart
CLVS [NASD]
Clovis Oncology, Inc.
Index- P/E- EPS (ttm)-4.45 Insider Own0.40% Shs Outstand53.14M Perf Week-5.78%
Market Cap2.48B Forward P/E- EPS next Y-3.61 Insider Trans-8.40% Shs Float50.90M Perf Month2.33%
Income-203.40M PEG- EPS next Q-1.87 Inst Own- Short Float17.08% Perf Quarter-12.48%
Sales67.00M P/S36.98 EPS this Y56.90% Inst Trans8.02% Short Ratio7.30 Perf Half Y-15.86%
Book/sh6.05 P/B7.71 EPS next Y38.30% ROA-47.60% Target Price75.29 Perf Year-47.54%
Cash/sh8.73 P/C5.34 EPS next 5Y- ROE-111.10% 52W Range41.31 - 99.45 Perf YTD-31.44%
Dividend- P/FCF- EPS past 5Y-5.70% ROI-27.30% 52W High-53.12% Beta1.29
Dividend %- Quick Ratio5.70 Sales past 5Y- Gross Margin80.50% 52W Low12.85% ATR2.23
Employees360 Current Ratio6.60 Sales Q/Q164.30% Oper. Margin- RSI (14)47.06 Volatility4.49% 4.82%
OptionableYes Debt/Eq0.92 EPS Q/Q-15.70% Profit Margin- Rel Volume0.54 Prev Close45.94
ShortableYes LT Debt/Eq0.92 EarningsAug 07 AMC Payout- Avg Volume1.19M Price46.62
Recom2.10 SMA20-0.53% SMA50-0.91% SMA200-20.41% Volume637,457 Change1.48%
Feb-22-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Feb-22-18Upgrade Evercore ISI In-line → Outperform
Oct-23-17Initiated Barclays Overweight $105
Sep-15-17Initiated RBC Capital Mkts Sector Perform $81
Aug-17-17Initiated Evercore ISI In-line $73
Jul-07-17Initiated Gabelli & Co Buy $125
Jun-23-17Initiated Oppenheimer Perform
Jun-20-17Upgrade Janney Neutral → Buy
Jun-19-17Upgrade Chardan Capital Markets Sell → Neutral $36 → $50
Jun-16-17Resumed Credit Suisse Outperform
Jun-13-17Initiated Leerink Partners Outperform $85
May-17-17Upgrade JP Morgan Neutral → Overweight
Feb-03-17Downgrade Chardan Capital Markets Neutral → Sell $36
Jan-27-17Initiated BofA/Merrill Buy $74
Jan-26-17Upgrade Piper Jaffray Neutral → Overweight
Jan-23-17Reiterated Stifel Buy $52 → $86
Jan-13-17Initiated Morgan Stanley Overweight
Dec-21-16Reiterated WallachBeth Hold $22 → $49
Dec-20-16Upgrade Chardan Capital Markets Sell → Neutral $15 → $36
Oct-25-16Initiated Chardan Capital Markets Sell $15
Jul-06-18 09:23AM  Clovis Gets EU Acceptance for Rubraca Label Expansion Filing Zacks +6.41%
08:56AM  Implied Volatility Surging for Clovis Oncology (CLVS) Stock Options Zacks
07:20AM  Free Technical Research on Clovis Oncology and Three More Biotech Equities ACCESSWIRE
Jul-05-18 08:00AM  Clovis Oncology Receives EMA Validation for its Application for a New Indication for Rubraca® (rucaparib) as Maintenance Treatment for Women with Recurrent Ovarian Cancer Business Wire
Jul-04-18 08:00AM  Today's Research Reports on Trending Tickers: Clovis Oncology and Global Blood Therapeutics ACCESSWIRE
Jun-26-18 07:50AM  Analysis: Positioning to Benefit within PBF Energy, Callaway Golf, Total System Services, Comcast, The Cheesecake Factory, and Clovis Oncology Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jun-21-18 08:25AM  Today's Research Reports on Trending Tickers: Clovis Oncology and Cronos Group ACCESSWIRE
Jun-14-18 08:10AM  Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Clovis Oncology ACCESSWIRE
Jun-11-18 04:05PM  Clovis Oncology to Present at the Goldman Sachs 39th Annual Global Healthcare Conference 2018 Business Wire
Jun-07-18 09:35AM  Clovis Oncology (CLVS) Up 11.5% Since Earnings Report: Can It Continue? Zacks
Jun-04-18 04:32PM  Why A Tie-Up With Clovis Helped This Biotech Spike To An 18-Year High Investor's Business Daily
06:00AM  Clovis Oncology Submits Application to EMA to Expand Use of Rubraca® (rucaparib) to Include Maintenance Treatment for Women with Recurrent Ovarian Cancer Business Wire
Jun-03-18 08:00PM  Clovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in Metastatic Triple-Negative Breast and Urothelial Cancers GlobeNewswire
May-30-18 10:37AM  Clovis' Rubraca Gets Approval in Europe for Ovarian Cancer Zacks
May-29-18 08:00AM  Clovis Oncology Announces European Commission Authorization of Rubraca® (rucaparib) for Women with Recurrent Ovarian Cancer Business Wire
May-16-18 11:55AM  Clovis Oncology Announces Presentations at 2018 ASCO Annual Meeting Business Wire
May-10-18 03:23PM  Former Biotech Darlings Tesaro, Clovis Pin Hopes on 2018 Rebound Bloomberg
09:24AM  Edited Transcript of CLVS earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-09-18 06:08PM  CORRECTING and REPLACING Clovis Oncology to Present at the Bank of America Merrill Lynch Healthcare Conference 2018 Business Wire +8.87%
11:09AM  Clovis (CLVS) Q1 Loss Wider Than Expected, Revenues Beat Zacks
07:35AM  Consolidated Research: 2018 Summary Expectations for Catalent, MGIC Investment, United Rentals, Clovis Oncology, Pure Storage, and Chipotle Mexican Grill Fundamental Analysis, Key Performance Indications GlobeNewswire
May-08-18 05:27PM  Clovis: 1Q Earnings Snapshot Associated Press
04:05PM  Clovis Oncology Announces First Quarter 2018 Operating Results Business Wire
08:51AM  How Has Clovis Oncology Incs (NASDAQ:CLVS) Earnings Fared Against The Long Term Trend Simply Wall St.
May-01-18 09:38AM  Is Clovis Oncology Incs (NASDAQ:CLVS) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Apr-24-18 04:15PM  Clovis Oncology to Announce First Quarter 2018 Financial Results and Host Webcast Conference Call on May 8 Business Wire
Apr-17-18 08:10AM  Todays Research Reports on Stocks to Watch: Clovis Oncology and Loxo Oncology ACCESSWIRE
Apr-16-18 08:54PM  Clovis Oncology Announces Pricing of Public Offerings of Convertible Senior Notes and Common Stock Business Wire -10.27%
06:44AM  Clovis Oncology Announces Proposed Offerings of Convertible Senior Notes and Common Stock Business Wire
Apr-10-18 08:30AM  Todays Research Reports on Trending Tickers: Clovis Oncology and Nektar Therapeutics ACCESSWIRE
Apr-09-18 09:54AM  Clovis' (CLVS) Rubraca Gets FDA Nod as Maintainence Therapy Zacks +5.89%
08:47AM  Clovis Oncology (CLVS) Surges: Stock Moves 5.9% Higher Zacks
08:30AM  Todays Research Reports on Trending Tickers: Clovis Oncology and CVS Health ACCESSWIRE
Apr-06-18 04:57PM  Clovis Oncology ovarian cancer drug receives fast-tracked FDA approval American City Business Journals +5.85%
04:12PM  Clovis Pops After Cancer Drug Gets OK; Smaller Players Crash Investor's Business Daily
01:38PM  Rubraca® (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer Business Wire
Mar-28-18 09:05AM  Why Is Clovis (CLVS) Down 9.3% Since its Last Earnings Report? Zacks
Mar-27-18 08:31PM  Tesaro Wants a Stronger Grip in Ovarian Cancer Motley Fool
04:21PM  Tesaro Sinks After Unveiling Results Of Merck-Tied Ovarian Cancer Study Investor's Business Daily
Mar-26-18 09:40AM  Clovis Gets Positive CHMP Opinion for Ovarian Cancer Drug Zacks
Mar-23-18 10:08AM  Loss-Making Clovis Oncology Inc (NASDAQ:CLVS) Expected To Breakeven Simply Wall St.
09:16AM  EMA panel for conditional OK to Clovis's ovarian cancer drug Reuters
08:52AM  Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe Business Wire
08:50AM  CHMP Grants Positive Opinion for Clovis Oncologys Rubraca® (rucaparib) Tablets Business Wire
Mar-20-18 08:10AM  Clovis Oncology, Analysts Review and Target Price, PDUFA Date, Milestones and Catalysts ACCESSWIRE
Mar-15-18 05:21PM  Edited Transcript of CLVS earnings conference call or presentation 26-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-09-18 07:44PM  AstraZeneca Goes Up Against 2 Cancer Upstarts Motley Fool
Mar-08-18 08:00AM  Clovis Oncology Announces Notice of Allowance for Rucaparib High Dosage Strength Tablet Patent with Expiration in 2035 Business Wire
Mar-07-18 04:05PM  Clovis Oncology to Present at the Barclays Global Healthcare Conference Business Wire
08:10AM  Research Report Identifies Tapestry, Burlington Stores, GoDaddy, Clovis Oncology, Darden Restaurants, and General Cable with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-28-18 08:44AM  Clovis Oncology (CLVS) Soars: Stock Adds 6.6% in Session Zacks
08:20AM  Todays Research Reports on Trending Tickers: Clovis Oncology and Exact Sciences ACCESSWIRE
Feb-27-18 04:27PM  These Biotechs Diverge After Biggest Moneymakers Lag Expectations Investor's Business Daily +6.56%
09:08AM  Clovis (CLVS) Q4 Loss Narrower Than Expected, Revenues Miss Zacks
07:10AM  Sierra Oncology Reports 2017 Year End Results CNW Group
Feb-26-18 05:25PM  Clovis reports 4Q loss Associated Press
04:05PM  Clovis Oncology Announces 2017 Operating Results Business Wire
12:30PM  Clovis Oncology, Inc. to Host Earnings Call ACCESSWIRE
11:23AM  Is There An Opportunity With Clovis Oncology Incs (NASDAQ:CLVS) 32.36% Undervaluation? Simply Wall St.
Feb-22-18 08:43AM  Is a Surprise Coming for Clovis Oncology (CLVS) This Earnings Season? Zacks +9.01%
Feb-21-18 05:10PM  Clovis Oncology Receives Positive Trend Vote from CHMP in European Regulatory Review for Rucaparib Ovarian Cancer Treatment Indication Business Wire
Feb-12-18 04:05PM  Clovis Oncology to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Webcast Conference Call on February 26 Business Wire
Jan-22-18 09:42AM  AstraZeneca's PARP Inhibitor Lynparza Gets Approval in Japan Zacks +6.89%
Jan-12-18 08:20AM  Todays Research Reports on Trending Tickers: Clovis Oncology and Incyte Corporation ACCESSWIRE
Jan-05-18 04:39PM  Why These 3 Biotech Stocks Could Outperform Their Peers In 2018 Investor's Business Daily
Jan-04-18 08:00AM  Clovis Oncology to Present at the 36th Annual J.P. Morgan Healthcare Conference Business Wire
Jan-02-18 08:04AM  See what the IHS Markit Score report has to say about Clovis Oncology Inc. Markit
Dec-28-17 09:10AM  Clovis Up More Than 50% in 2017: What's Driving the Stock? Zacks
Dec-19-17 08:00AM  Rucaparib MAA for the Ovarian Cancer Treatment Indication Referred by CHMP to Scientific Advisory Group on Oncology for Review Expected in February 2018 Business Wire
Dec-15-17 03:00AM  Clovis Oncology Shows Rising Relative Strength; Still Shy Of Key Threshold Investor's Business Daily
Dec-13-17 12:41PM  Value Biotech ETFs to Buy Now Zacks
Dec-06-17 03:09PM  Clovis' sNDA for Rubraca Gets Priority Review in the U.S. Zacks
02:08PM  Why Clovis' Good News In Ovarian Cancer Prodded These Rivals Down Investor's Business Daily
09:30AM  Clovis Up On Priority Review Status for Ovarian Cancer Therapy -- Biotech Movers TheStreet.com
09:30AM  Clovis Up on Priority Review Status for Ovarian Cancer Therapy -- Biotech Mover TheStreet.com
07:46AM  Biotech Stock Roundup: FDA Nod for Amgen PCSK9 Inhibitor, Revance Up on RT002 Data Zacks
Dec-05-17 08:25PM  Clovis Oncology gets FDA fast-tracked review date for ovarian cancer drug American City Business Journals
04:05PM  Clovis Announces Priority Review Designation for Rucaparib Supplemental New Drug Application Business Wire
Nov-28-17 11:58AM  Biotech Pullback Makes Bargains Out Of Alexion, Flexion, Clovis, Tesaro And Incyte Forbes
Nov-27-17 08:04AM  See what the IHS Markit Score report has to say about Clovis Oncology Inc. Markit
Nov-24-17 11:24AM  3 Companies Competing to Gain Lead in Ovarian Cancer Market Zacks
Nov-21-17 10:25AM  TESARO (TSRO) Ovarian Cancer Drug Zejula Gets Approval in EU Zacks
08:03AM  See what the IHS Markit Score report has to say about Clovis Oncology Inc. Markit
Nov-20-17 08:20AM  Todays Research Reports on Trending Tickers: Ekso Bionics and Clovis Oncology ACCESSWIRE
Nov-15-17 08:03AM  See what the IHS Markit Score report has to say about Clovis Oncology Inc. Markit
Nov-14-17 02:55PM  CORRECTING and REPLACING Recent Analysis Shows Pure Storage, Catalent, Boyd Gaming, Halozyme Therapeutics, Clovis Oncology, and General Cable Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-13-17 06:45PM  Edited Transcript of CLVS earnings conference call or presentation 1-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
07:50AM  Recent Analysis Shows Pure Storage, Catalent, Boyd Gaming, Halozyme Therapeutics, Clovis Oncology, and General Cable Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-08-17 06:40PM  Clovis Oncology to Present at the Stifel 2017 Healthcare Conference Business Wire
01:45PM  Clovis Oncology, Inc. breached its 50 day moving average in a Bullish Manner : CLVS-US : November 8, 2017 Capital Cube
07:40AM  Corporate News Blog - AVEO and EUSA Pharma Report Positive Results for TiNivo Study of Tivozanib and Nivolumab ACCESSWIRE
Nov-02-17 11:49AM  Clovis (CLVS) Q3 Loss Wider Than Expected, Revenues Miss Zacks
Nov-01-17 06:26PM  Clovis reports 3Q loss Associated Press
05:47PM  Neurocrine, Exelixis, Juno Stocks Rocket After Crushing Views Investor's Business Daily
04:05PM  Clovis Oncology Announces Third Quarter 2017 Operating Results Business Wire
12:00PM  Clovis Oncology, Inc. to Host Earnings Call ACCESSWIRE
Oct-30-17 11:13AM  What's in the Cards for Immune Design (IMDZ) in Q3 Earnings? Zacks
Oct-26-17 12:16PM  Allergan (AGN) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-25-17 10:23AM  Clovis Oncology, Inc. Value Analysis (NASDAQ:CLVS) : October 25, 2017 Capital Cube
07:00AM  Sierra Oncology Appoints Dr. Andrew Allen to its Board of Directors CNW Group
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. Its commercial product includes Rubraca (rucaparib) tablet, a small molecule poly ADP-ribose polymerase inhibitor, used as monotherapy for the treatment of patients with deleterious BRCA mutation associated advanced ovarian cancer, who have been treated with two or more chemotherapies, and selected for therapy by an FDA-approved companion diagnostic for Rubraca. The company's product candidates include lucitanib, an oral inhibitor of the tyrosine kinase activity of vascular endothelial growth factor receptors, platelet-derived growth factor receptors alpha and beta, and fibroblast growth factor receptors; and rociletinib, an oral mutant-selective inhibitor of epidermal growth factor receptor. It distributes its products primarily through specialty distributors and pharmacy providers to patients and health care providers. The company has license agreements with Pfizer Inc., AstraZeneca UK Limited, Advenchen Laboratories LLC, and Celgene Corporation; collaboration and license agreement with Les Laboratoires Servier; a clinical collaboration with Bristol-Myers Squibb Company; a partnership with Foundation Medicine, Inc; and a diagnostic collaboration with Myriad Genetics, Inc. Clovis Oncology, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPICKSCHEN THORLEFDirectorApr 09Sale60.024,500270,0907,618Apr 09 06:28 PM
SPICKSCHEN THORLEFDirectorMar 08Sale61.474,500276,61512,118Mar 09 08:34 PM
SPICKSCHEN THORLEFDirectorFeb 22Sale60.004,500270,00016,618Feb 23 05:14 PM
IVERS-READ GILLIAN CSee RemarksFeb 15Sale54.093,000162,270180,571Feb 16 07:54 PM
IVERS-READ GILLIAN CSee RemarksJan 16Sale59.163,000177,480183,571Jan 17 04:45 PM
SPICKSCHEN THORLEFDirectorJan 08Sale64.974,500292,36521,118Jan 09 04:45 PM
IVERS-READ GILLIAN CSee RemarksDec 15Sale64.163,000192,480182,583Dec 18 04:45 PM
SPICKSCHEN THORLEFDirectorDec 08Sale60.004,500270,00025,618Dec 08 09:32 PM
IVERS-READ GILLIAN CSee RemarksNov 15Sale63.703,000191,100185,583Nov 16 04:45 PM
IVERS-READ GILLIAN CSee RemarksOct 16Sale84.543,000253,620188,583Oct 17 08:13 PM
IVERS-READ GILLIAN CSee RemarksSep 15Sale69.503,000208,500191,583Sep 18 04:35 PM
IVERS-READ GILLIAN CSee RemarksAug 15Sale70.053,000210,150194,583Aug 15 04:53 PM
BLAIR JAMES CDirectorAug 04Sale78.6118,4501,450,35517,056Aug 08 04:03 PM
HCI HCI Group, Inc. daily Stock Chart
HCI [NYSE]
HCI Group, Inc.
Index- P/E- EPS (ttm)-1.07 Insider Own11.70% Shs Outstand9.24M Perf Week1.85%
Market Cap386.14M Forward P/E9.19 EPS next Y4.55 Insider Trans0.00% Shs Float7.24M Perf Month-5.11%
Income-9.00M PEG- EPS next Q1.02 Inst Own76.50% Short Float11.19% Perf Quarter1.85%
Sales235.40M P/S1.64 EPS this Y-131.30% Inst Trans0.08% Short Ratio12.10 Perf Half Y22.19%
Book/sh23.87 P/B1.75 EPS next Y15.73% ROA- Target Price48.25 Perf Year-8.72%
Cash/sh24.48 P/C1.71 EPS next 5Y25.00% ROE- 52W Range27.11 - 47.58 Perf YTD39.77%
Dividend1.50 P/FCF- EPS past 5Y-18.10% ROI2.00% 52W High-12.17% Beta1.63
Dividend %3.59% Quick Ratio- Sales past 5Y8.50% Gross Margin- 52W Low54.15% ATR0.94
Employees410 Current Ratio- Sales Q/Q-14.90% Oper. Margin- RSI (14)49.02 Volatility1.61% 2.39%
OptionableYes Debt/Eq1.24 EPS Q/Q-16.50% Profit Margin- Rel Volume0.52 Prev Close41.52
ShortableYes LT Debt/Eq1.24 EarningsAug 01 AMC Payout- Avg Volume66.97K Price41.79
Recom2.20 SMA200.07% SMA50-0.60% SMA20012.33% Volume35,115 Change0.65%
Sep-11-17Upgrade Sidoti Neutral → Buy
Apr-07-17Initiated SunTrust Buy $52
Dec-28-15Initiated Piper Jaffray Overweight
Oct-20-15Upgrade JMP Securities Mkt Perform → Mkt Outperform $47
Mar-17-15Downgrade Gilford Securities Buy → Neutral $50
Oct-03-14Upgrade Gilford Securities Neutral → Buy $46.50 → $52
Oct-24-13Downgrade Gilford Securities Buy → Neutral $44.50 → $45.60
Aug-30-13Upgrade Gilford Securities Neutral → Buy $37.50 → $44.50
Aug-02-13Reiterated Gilford Securities Neutral $36 → $37.50
May-28-13Downgrade Taglich Brothers Buy → Speculative Buy $22 → $38
May-08-13Downgrade Gilford Securities Buy → Neutral
Apr-01-13Reiterated Taglich Brothers Buy $27.35 → $31.95
Mar-06-13Reiterated Gilford Securities Buy $26 → $30
Jul-16-18 05:00PM  HCI Group Sets Second Quarter 2018 Earnings Call for Thursday, August 2, 2018 at 4:45 p.m. ET GlobeNewswire
Jul-06-18 08:00AM  HCI Group Declares Q3 2018 Regular Quarterly Cash Dividend GlobeNewswire
Jun-27-18 02:58PM  How shareholders had their say on pay at two of Tampa Bays biggest companies American City Business Journals
Jun-26-18 11:22AM  Allstate (ALL) Catastrophe Woes Continue With Losses in May Zacks
09:30AM  Is HCI Group (HCI) Outperforming Other Finance Stocks This Year? Zacks
Jun-18-18 10:34AM  Here's Why You Should Hold on to Hartford Financial Stock Zacks
Jun-06-18 01:51PM  Heres why property insurance premiums could be going up in Florida and in Tampa Bay American City Business Journals
08:00AM  HCI Group Completes its 2018-2019 CAT Reinsurance Program, Reduces Risk Retention GlobeNewswire
Jun-05-18 12:37PM  4 Best Value Bets From Undervalued P&C Insurance Industry InvestorPlace
May-29-18 09:34AM  Top Ranked Income Stocks to Buy for May 29th Zacks
May-21-18 08:20AM  Report: Exploring Fundamental Drivers Behind Syros Pharmaceuticals, J & J Snack Foods, Wright Medical Group N.V, HCI Group, Tennant, and Ebix New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
May-18-18 05:22PM  Edited Transcript of HCI earnings conference call or presentation 1-May-18 8:45pm GMT Thomson Reuters StreetEvents
May-01-18 06:22PM  HCI Group: 1Q Earnings Snapshot Associated Press
04:15PM  HCI Group Reports First Quarter 2018 Results GlobeNewswire
Apr-25-18 08:00AM  HCI Group Launches InsurTech Platform for Homeowners Insurance GlobeNewswire
Apr-18-18 09:34AM  HCI Group Rewards Shareholders With 7.1% Dividend Raise Zacks
Apr-17-18 08:00AM  HCI Group Increases Quarterly Cash Dividend 7.1% to 37.5 Cents GlobeNewswire
Apr-12-18 08:00AM  HCI Group InsurTech Platform Surpasses $10 Million GlobeNewswire
Apr-10-18 08:00AM  HCI Group Sets First Quarter 2018 Earnings Call for Tuesday, May 1, 2018 at 4:45 p.m. ET GlobeNewswire
Mar-23-18 07:35AM  Recent Analysis Shows Asbury Automotive Group, PJT Partners, eHealth, HCI Group, Getty Realty, and TPG Specialty Lending Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Mar-12-18 04:15PM  HCI Group Sets 2018 Annual Shareholders' Meeting and Record Date GlobeNewswire
Mar-07-18 08:21PM  Edited Transcript of HCI earnings conference call or presentation 6-Mar-18 9:45pm GMT Thomson Reuters StreetEvents +13.92%
10:31AM  HCI Group (HCI) Q4 Earnings Beat Estimates, Revenues In Line Zacks
Mar-06-18 06:37PM  HCI Group posts 4Q profit Associated Press
04:15PM  HCI Group Reports Fourth Quarter and Full Year 2017 Results GlobeNewswire
12:30PM  HCI Group, Inc. to Host Earnings Call ACCESSWIRE
08:19AM  At $36.66, Is It Time To Buy HCI Group Inc (NYSE:HCI)? Simply Wall St.
Feb-12-18 08:00AM  HCI Group Sets Fourth Quarter and Full Year 2017 Earnings Call for Tuesday, March 6, 2018 at 4:45 p.m. ET GlobeNewswire
Jan-24-18 08:30AM  Market Trends Toward New Normal in HCI Group, Mitek, Duluth, Gentherm, Masonite International, and AmeriGas Partners Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jan-22-18 08:00AM  HCI Group Declares Q1 2018 Regular Quarterly Cash Dividend GlobeNewswire
Jan-16-18 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in California GlobeNewswire
Dec-28-17 08:20AM  Year in Review: First Coast's tech successes in 2017 American City Business Journals
Dec-15-17 01:29PM  ETFs with exposure to HCI Group, Inc. : December 15, 2017 Capital Cube
Dec-12-17 08:00AM  HCI Group Appoints Karin Coleman to Executive Vice President GlobeNewswire
Dec-06-17 08:00AM  HCI Group Board Authorizes $20 Million Stock Repurchase Program for 2018 GlobeNewswire
Dec-05-17 12:56PM  ETFs with exposure to HCI Group, Inc. : December 5, 2017 Capital Cube
Dec-01-17 08:45AM  HCI Group, Inc. :HCI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017 Capital Cube
Nov-30-17 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Ohio GlobeNewswire
Nov-17-17 10:17AM  HCI Group, Inc. : HCI-US: Dividend Analysis : November 17th, 2017 (record date) : By the numbers : November 17, 2017 Capital Cube
Nov-07-17 07:34PM  Edited Transcript of HCI earnings conference call or presentation 2-Nov-17 8:45pm GMT Thomson Reuters StreetEvents
Nov-06-17 11:45AM  ETFs with exposure to HCI Group, Inc. : November 6, 2017 Capital Cube
05:38AM  HCI Group reports 3Q loss Associated Press
Nov-02-17 04:15PM  HCI Group Reports Third Quarter and Nine-Month 2017 Results GlobeNewswire
12:20PM  HCI Group, Inc. to Host Earnings Call ACCESSWIRE
Nov-01-17 08:27AM  HCI Group, Inc. breached its 50 day moving average in a Bearish Manner : HCI-US : November 1, 2017 Capital Cube
Oct-27-17 08:00AM  HCI Group Real Estate Division Acquires New Office Building GlobeNewswire
Oct-24-17 08:00AM  HCI Group Declares Q4 2017 Regular Quarterly Cash Dividend GlobeNewswire
Oct-20-17 09:17AM  New Strong Sell Stocks for October 20th Zacks
Oct-17-17 10:13AM  HCI Group, Inc. Value Analysis (NYSE:HCI) : October 17, 2017 Capital Cube
Oct-16-17 08:09AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : October 16, 2017 Capital Cube
Oct-09-17 08:00AM  HCI Group Sets Third Quarter 2017 Earnings Call for Thursday, November 2, 2017 at 4:45 p.m. ET GlobeNewswire
Oct-06-17 05:06PM  State Auto Financial (STFC) Projects Q3 Cat Loss Estimates Zacks
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in North Carolina GlobeNewswire
Sep-27-17 09:29AM  United Insurance (UIHC) Keeps a Count of Q3 Catastrophe Loss Zacks
Sep-25-17 04:00PM  Allstate Estimates Catastrophe Loss from Hurricane Harvey Zacks
Sep-21-17 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in New Jersey GlobeNewswire
Sep-19-17 10:33AM  HCI Group (HCI) Calculates Possible Irma Catastrophe Loss Zacks
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Texas GlobeNewswire
Sep-18-17 05:56PM  ETFs with exposure to HCI Group, Inc. : September 18, 2017 Capital Cube
08:00AM  HCI Group Insurance Subsidiaries Issue Loss Estimates from Hurricane Irma GlobeNewswire
Sep-15-17 03:16PM  HCI Group, Inc. : HCI-US: Dividend Analysis : August 18th, 2017 (record date) : By the numbers : September 15, 2017 Capital Cube
11:51AM  HCI Group, Inc. :HCI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 15, 2017 Capital Cube
Sep-12-17 05:00PM  Universal Insurance and other big Florida insurers see a quick rebound in stock prices American City Business Journals
Sep-11-17 08:05AM  How Tampa Bay and Florida insurers are making it through the storm American City Business Journals +17.48%
Sep-08-17 01:40PM  Hurricane Irma causes Florida insurance stocks to plunge American City Business Journals
10:22AM  The Zacks Analyst Blog Highlights: HCI Group, Lumber Liquidators, Tempur Sealy International and Home Depot Zacks
Sep-07-17 04:30PM  Hurricane Irma: These Insurance Stocks Have the Most Exposure to Florida Zacks -8.46%
08:48AM  HCI Group (HCI) in Focus: Stock Moves 5.8% Higher Zacks
Sep-06-17 11:08AM  ETFs to Watch in Harvey Aftermath & New Hurricane Irma Zacks +5.79%
Sep-05-17 03:25PM  Irma batters Tampa Bay insurance stocks American City Business Journals -20.01%
Aug-25-17 08:15AM  HCI Group to Participate at the 6th Annual Liolios Gateway Conference and the 2017 KBW Insurance Conference in September 2017 GlobeNewswire
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in South Carolina GlobeNewswire
Aug-23-17 08:34AM  Liolios Releases Presenting Company Roster for its 6th Annual Gateway Conference on September 6-7 in San Francisco GlobeNewswire
Aug-17-17 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Maryland GlobeNewswire
Aug-12-17 01:50AM  Edited Transcript of HCI earnings conference call or presentation 2-Aug-17 8:45pm GMT Thomson Reuters StreetEvents
Aug-04-17 03:22AM  HCI Group posts 2Q profit Associated Press
Aug-02-17 04:15PM  HCI Group Reports Second Quarter and Six-Month 2017 Results GlobeNewswire
Aug-01-17 04:10PM  Investor Network Invites You to the HCI Group Second Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, August 2, 2017 ACCESSWIRE
Jul-31-17 06:25PM  HCI Group, Inc. Value Analysis (NYSE:HCI) : July 31, 2017 Capital Cube
Jul-17-17 09:48AM  HCI Group, Inc. breached its 50 day moving average in a Bearish Manner : HCI-US : July 17, 2017 Capital Cube
Jul-14-17 08:05AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Pennsylvania GlobeNewswire
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Arkansas GlobeNewswire
Jul-10-17 08:00AM  HCI Group Declares Q3 2017 Regular Quarterly Cash Dividend GlobeNewswire
Jun-22-17 08:00AM  HCI Group Insurance Subsidiaries Expand Flood Insurance into Nine Additional States GlobeNewswire
Jun-13-17 04:15PM  HCI Group to Participate at the JMP Financial Services and Real Estate Conference on Thursday, June 22, 2017 GlobeNewswire
Jun-12-17 02:07PM  ETFs with exposure to HCI Group, Inc. : June 12, 2017 Capital Cube
Jun-09-17 09:46AM  HCI Group, Inc. :HCI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017 Capital Cube
08:10AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : June 9, 2017 Capital Cube
Jun-01-17 08:30AM  HCI Group Insurance Subsidiary, Homeowners Choice, Improves Coverage and Reduces Risk GlobeNewswire
May-19-17 12:11PM  HCI Group, Inc. : HCI-US: Dividend Analysis : May 19th, 2017 (record date) : By the numbers : May 19, 2017 Capital Cube
May-10-17 07:05PM  Edited Transcript of HCI earnings conference call or presentation 4-May-17 8:45pm GMT Thomson Reuters StreetEvents
May-05-17 05:03AM  HCI Group posts 1Q profit Associated Press
May-04-17 04:15PM  HCI Group Reports First Quarter 2017 Results GlobeNewswire
May-03-17 04:10PM  Investor Network Invites You to the HCI Group First Quarter 2017 Earnings Conference Call and Webcast Live on Thursday, May 4, 2017 Accesswire
Apr-26-17 08:22AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : April 26, 2017 Capital Cube
Apr-24-17 03:10PM  Heres what happened when HCI Groups biggest shareholder bought more stock American City Business Journals
08:00AM  HCI Group Terminates Shareholder Rights Plan GlobeNewswire
Apr-19-17 08:00AM  HCI Group Declares Q2 2017 Regular Quarterly Cash Dividend GlobeNewswire
Apr-17-17 08:00AM  HCI Group Sets First Quarter 2017 Earnings Call for Thursday, May 4, 2017 at 4:45 p.m. ET GlobeNewswire
Apr-12-17 08:05AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : April 12, 2017 Capital Cube
HCI Group, Inc. primarily engages in the property and casualty insurance business in Florida. It provides property and casualty insurance to homeowners, condominium owners, and tenants; and reinsurance. The company also owns and operates one full-service restaurant, two marinas, two retail shopping centers, and one office building. In addition, it offers designs and develops Web-based applications and products for mobile devices. The company was formerly known as Homeowners Choice, Inc. and changed its name to HCI Group, Inc. in May 2013. HCI Group, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Politis GregoryDirectorDec 19Buy29.102,00058,200196,000Dec 21 04:03 PM
Politis GregoryDirectorDec 18Buy29.972,00059,946194,000Dec 19 03:51 PM
Politis GregoryDirectorDec 15Buy29.282,00058,552192,000Dec 19 03:51 PM
Patel PareshChief Executive OfficerDec 08Buy30.301,00030,30035,000Dec 12 03:50 PM
Macchiarola James JDirectorNov 27Buy30.446,000182,6236,000Nov 29 03:55 PM
Harmsworth James MarkChief Financial OfficerSep 21Buy36.9350018,467500Sep 21 04:33 PM
Graham Andrew L.GC/Corporate SecretarySep 21Buy36.45652,3692,825Sep 21 04:31 PM
Patel PareshChief Executive OfficerSep 20Buy36.061,00036,062285,000Sep 21 04:29 PM
EDN Empresa Distribuidora y Comercializadora Norte Sociedad Anonima daily Stock Chart
EDN [NYSE]
Empresa Distribuidora y Comercializadora Norte Sociedad Anonima
Index- P/E22.64 EPS (ttm)1.40 Insider Own52.20% Shs Outstand22.83M Perf Week-9.31%
Market Cap724.62M Forward P/E4.39 EPS next Y7.22 Insider Trans0.00% Shs Float21.50M Perf Month-24.91%
Income63.00M PEG0.35 EPS next Q- Inst Own24.00% Short Float0.61% Perf Quarter-43.37%
Sales1.10B P/S0.66 EPS this Y157.30% Inst Trans0.42% Short Ratio1.35 Perf Half Y-43.31%
Book/sh2.01 P/B15.79 EPS next Y22.01% ROA6.90% Target Price61.00 Perf Year3.76%
Cash/sh8.01 P/C3.96 EPS next 5Y64.70% ROE129.00% 52W Range27.92 - 63.29 Perf YTD-36.14%
Dividend- P/FCF10.13 EPS past 5Y21.60% ROI38.60% 52W High-49.85% Beta1.70
Dividend %- Quick Ratio0.90 Sales past 5Y52.20% Gross Margin47.20% 52W Low13.68% ATR2.94
Employees4789 Current Ratio0.90 Sales Q/Q105.20% Oper. Margin14.20% RSI (14)33.35 Volatility6.93% 9.27%
OptionableNo Debt/Eq1.91 EPS Q/Q243.70% Profit Margin5.70% Rel Volume3.04 Prev Close32.88
ShortableYes LT Debt/Eq1.84 EarningsAug 10 BMO Payout0.00% Avg Volume96.92K Price31.74
Recom2.60 SMA20-12.19% SMA50-24.25% SMA200-35.18% Volume294,535 Change-3.47%
May-30-18Downgrade Morgan Stanley Overweight → Equal-Weight
May-28-08Downgrade Citigroup Buy → Hold
May-12-08Downgrade JP Morgan Overweight → Neutral
Jun-15-07Initiated Bear Stearns Outperform $24
Jun-14-18 01:13PM  Want To Invest In Edison SA. (WSE:EDN)? Heres How It Performed Lately Simply Wall St. -8.33%
May-24-18 05:51AM  Is Edison SA. (WSE:EDN) A Financially Sound Company? Simply Wall St.
May-21-18 10:03PM  Edited Transcript of EDN.BA earnings conference call or presentation 14-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-09-18 11:27AM  Should You Be Tempted To Buy Edison SA. (WSE:EDN) At Its Current PE Ratio? Simply Wall St.
May-07-18 08:10AM  Empresa Distribuidora (EDN) Enters Oversold Territory Zacks
May-02-18 11:02AM  Edison SA. (WSE:EDN) Delivered A Better ROE Than The Industry, Heres Why Simply Wall St.
Nov-27-17 01:15PM  ETFs with exposure to Edenor SA : November 27, 2017 Capital Cube
Nov-15-17 11:46AM  ETFs with exposure to Edenor SA : November 15, 2017 Capital Cube
Sep-15-17 11:35PM  [$$] Argentina Makes Progress on Economic Reforms Barrons.com
May-24-17 10:21AM  Edenor SA :EDN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017 Capital Cube
Apr-28-17 04:32PM  Edenor Informs The Market Of The Filing Of Its Annual Report On Form 20-F For The Fiscal Year Ended December 31, 2016. PR Newswire
Apr-11-17 01:40PM  Edenor SA :EDN-US: Earnings Analysis: Q4, 2016 By the Numbers : April 11, 2017 Capital Cube
11:13AM  Edenor SA :EDN-US: Earnings Analysis: 2016 By the Numbers : April 11, 2017 Capital Cube
Feb-08-17 10:25AM  Top Ranked Momentum Stocks to Buy for February 8th Zacks
Feb-01-17 08:45AM  Empresa (EDN) Worth a Looks: Stock Adds 7.6% in Session Zacks
Dec-01-16 04:47PM  5 Utility Stocks You Can Do Without This December
Nov-21-16 11:06AM  Edenor SA :EDN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016 Capital Cube
11:06AM  Edenor SA :EDN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016
Aug-19-16 10:58AM  Edenor SA :EDN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 19, 2016 Capital Cube
10:58AM  Edenor SA :EDN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 19, 2016
Aug-18-16 05:21PM  Argentina: Tax Amnesty For $400B In Hidden Assets? at Barrons.com
Jul-27-16 01:04PM  EDENOR Financials
May-26-16 11:39AM  Edenor SA :EDN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016
May-11-16 12:43PM  Genneia S.A. -- Moody's recalibrates Argentina's national rating scale and repositions national scale ratings of infrastructure issuers. Moody's
12:43PM  Genneia S.A. -- Moody's recalibrates Argentina's national rating scale and repositions national scale ratings of infrastructure issuers. at Moody's
May-04-16 01:04PM  EDENOR Financials EDGAR Online Financials
Apr-27-16 07:32PM  Edenor informs the market of the filing of its annual report on form 20-F for the fiscal year ended december 31, 2015 PR Newswire
Apr-21-16 03:20PM  Genneia S.A. -- Moody's upgrades Argentine Utilities and Infrastructure issuers Moody's
03:20PM  Genneia S.A. -- Moody's upgrades Argentine Utilities and Infrastructure issuers at Moody's
03:12PM  Aeropuertos Argentina 2000 S.A. -- Moody's upgrades Argentine Utilities and Infrastructure issuers at Moody's
03:12PM  Aeropuertos Argentina 2000 S.A. -- Moody's upgrades Argentine Utilities and Infrastructure issuers at Moody's
Mar-23-16 10:42AM  Edenor SA :EDN-US: Earnings Analysis: Q4, 2015 By the Numbers Capital Cube
Mar-22-16 02:22PM  Edenor SA :EDN-US: Earnings Analysis: 2015 By the Numbers
Feb-01-16 07:23PM  Empresa Distribuidora Norte S.A. -- Moody's upgrades Edenor ratings to Caa2/Ba2.ar; outlook positive Moody's
07:12PM  Empresa Distribuidora Norte S.A. -- Moody's upgrades Edenor ratings to Caa2; outlook positive at Moody's
Dec-21-15 01:10PM  Edenor SA Earnings Analysis: Q3, 2015 By the Numbers
Nov-27-15 08:27PM  More And More Hedge Funds Are Selling Silver Bay Realty Trust Corp (SBY) at Insider Monkey
Nov-26-15 03:49AM  Is Blueprint Medicines Corp (BPMC) Going to Burn These Hedge Funds? at Insider Monkey
Nov-16-15 09:00PM  Zombie Bonds No More as Argentina Vote Stokes Utilities Windfall at Bloomberg
Nov-04-15 05:45PM  Genneia S.A. -- Moody's changes outlook to stable for Argentine Infrastructure Issuers; places Edenor under review for upgrade at Moody's
05:38PM  Aeropuertos Argentina 2000 S.A. -- Moody's changes EDESA's outlook to stable, affirms TGS and AA2000 ratings and places Edenor under review for upgrade at Moody's
Aug-28-15 11:49AM  Edenor SA Earnings Q2, 2015
Aug-24-15 06:21PM  Edenor Informs The Market Of The Filing Of Its Annual Report On Form 20-F For The Fiscal Year Ended December 31, 2014 PR Newswire
03:56PM  Argentina To Sell State Stake In Stocks? at Barrons.com
Jul-10-15 11:35AM  Mid-Morning Market Update: Markets Surge; PriceSmart Posts Mixed Results
Mar-18-15 08:18AM  Fourth Q.14 - Earnings Release at noodls
Jan-09-15 01:45PM  EDENOR S.A. Informs to the Market that it has Filed its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2013 PR Newswire
Sep-05-14 06:01PM  Emerging Market Week in Review at Barrons.com
Sep-04-14 05:42PM  Argentina Stocks Drop On Bond Default Vote at Barrons.com
Aug-28-14 11:14AM  Empresa Distribuidora Y Comercializadora No Stock Downgraded (EDN) at TheStreet
Aug-26-14 02:56PM  Kite Pharmaceuticals Releases Positive Non-Hodgkin's Lymphoma Result; iKang Healthcare Disappoints
01:10PM  DSW Jumps On Upbeat Results; Trina Solar Shares Drop
Jul-31-14 10:09AM  [video] Argentina disputing debt default at CNBC
09:15AM  [video] ISDA requested to make Argentina ruling at CNBC
07:03AM  [video] Argentine stocks tumble after default news at CNBC
Jul-09-14 01:03PM  Today's Top Performers In Utilities at TheStreet
Jul-01-14 05:46PM  4 Emerging Markets Stocks On Winning Streaks at Seeking Alpha
Jun-26-14 02:10PM  What Will Happen to These ADRs if Argentina Defaults? at Motley Fool
Jun-24-14 03:15PM  Utility Sector Rises; Elizabeth Arden Shares Slide Over 3.6% Benzinga
12:36PM  Micron Gains On Upbeat Earnings; Elizabeth Arden Shares Slide Benzinga
Jun-17-14 09:26AM  Stock Downgrades: Travelers Going Nowhere Fast at Minyanville
05:49AM  Argentina refuses to submit to 'extortion' on debt at Financial Times
04:44AM  Argentina Heads For Another Sovereign Default at Forbes
Mar-17-14 07:46AM  4 Stocks Under $10 Making Big Moves at TheStreet
Mar-11-14 04:57AM  SectorCast Rankings Take A Neutral Slant As Market Hits New Highs at Seeking Alpha
Feb-08-14 10:18AM  Edenor: Trading At A Bargain Price at Seeking Alpha
Jan-26-14 08:23AM  Avoid Argentina Stocks This Year at Seeking Alpha
Dec-13-13 09:34AM  4 Stocks Under $10 to Trade for Breakouts Optionetics
Nov-15-13 08:13AM  4 Stocks Under $10 to Trade for Breakouts Optionetics
Sep-06-13 03:24PM  Empresa Distribuidora Norte S.A. -- Moody's downgrades Edenor's to Caa3/Caa3.ar; Negative outlook Moody's
Apr-16-13 06:40PM  Dividend yielding stocks that stand apart as multiples swell at MarketWatch
Feb-26-13 10:34AM  Argentina's Errant Energy Policy at Motley Fool
Nov-26-12 04:13AM  Should You Invest In Argentina Stocks Now? at Seeking Alpha
Aug-24-12 04:41PM  Utilities Sector Wrap at Fox Business
Jul-25-12 05:40PM  Utilities Sector Wrap at Fox Business
Jul-05-12 05:39PM  Utilities Sector Wrap at Fox Business
Jun-04-12 05:12PM  Utilities Sector Wrap at Fox Business
May-31-12 04:56PM  Utilities Sector Wrap at Fox Business
May-23-12 12:50PM  Empresa Distribuidora y Comercializadora Norte, School Specialty: Biggest Price Gainers (EDN, SCHS) at The Wall Street Journal
May-21-12 04:56PM  Utilities Sector Wrap at Fox Business
May-09-12 04:56PM  Utilities Sector Wrap at Fox Business
May-08-12 04:56PM  Utilities Sector Wrap at Fox Business
Apr-27-12 11:20AM  Are Argentinean Companies at Risk of Being Expropriated? at Motley Fool
Apr-26-12 04:56PM  Utilities Sector Wrap at Fox Business
04:04PM  Edenor Informs the Market of the Filing of its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2011 PR Newswire
Apr-23-12 09:06AM  Argentina's Wasted Chances at Seeking Alpha
Apr-18-12 10:26AM  Polaris, Calpine hit new highs; Seagate active at MarketWatch
Apr-17-12 07:34PM  YPF slumps to three-year low on takeover move at MarketWatch
04:50PM  Empresa Distribuidora y Comercializadora Norte, China Finance Online: Biggest Price Decliners (EDN, JRJC) at The Wall Street Journal
12:06PM  Tuesday Sector Laggards: Electric Utilities, Cigarettes & Tobacco Stocks at Forbes
11:30AM  [video] Tuesday Sector Laggards: Electric Utilities, Cigarettes & Tobacco Stocks at Forbes
Dec-20-11 03:30AM  2 Utilities To Add Utility To Your Portfolio at Seeking Alpha
Nov-03-11 03:39AM  10 Foreign Utility Stocks To Consider at Seeking Alpha
Nov-01-11 10:58AM  The AES Corp Third Quarter Earnings Sneak Peek Wall St. Cheat Sheet
Oct-20-11 12:13PM  El Paso Corporation and Williams Companies Lead the Way Higher in the Utilities Sector Wall St. Cheat Sheet
Oct-11-11 02:44PM  The Fastest-Growing Electric Utility Stocks at Motley Fool
Aug-05-11 08:30AM  The AES Earnings Cheat Sheet: Revenue, Net Income Climbs Wall St. Cheat Sheet
Jul-28-11 07:07PM  The AES Corp Second Quarter Earnings Sneak Peek Wall St. Cheat Sheet
Jul-22-11 12:00AM  Italian Stocks - Factors to watch on July 22 at Reuters
Jul-15-11 03:25PM  Vectren Corp Passes Through 5% Yield Mark at Forbes
Empresa Distribuidora y Comercializadora Norte Sociedad Anonima, a public service company, engages in the distribution and sale of electricity in Argentina. It serves approximately 8.5 million people in the northwestern part of the greater Buenos Aires metropolitan area and the northern part of the City of Buenos Aires through the concession of 4,637 square kilometers. The company was formerly known as Empresa Distribuidora Norte Sociedad Anonima and changed its name to Empresa Distribuidora y Comercializadora Norte Sociedad Anonima in June 1996. The company was founded in 1992 and is based in Buenos Aires, Argentina. Empresa Distribuidora y Comercializadora Norte Sociedad Anonima is a subsidiary of Electricidad Argentina S.A.
KLIC Kulicke and Soffa Industries, Inc. daily Stock Chart
KLIC [NASD]
Kulicke and Soffa Industries, Inc.
Index- P/E13.05 EPS (ttm)2.15 Insider Own0.40% Shs Outstand70.36M Perf Week8.37%
Market Cap1.98B Forward P/E12.74 EPS next Y2.21 Insider Trans-6.55% Shs Float67.33M Perf Month16.94%
Income154.00M PEG1.09 EPS next Q0.61 Inst Own88.10% Short Float1.75% Perf Quarter6.81%
Sales895.30M P/S2.21 EPS this Y155.80% Inst Trans-0.87% Short Ratio1.42 Perf Half Y13.08%
Book/sh12.51 P/B2.25 EPS next Y-0.68% ROA4.10% Target Price32.16 Perf Year24.79%
Cash/sh8.93 P/C3.15 EPS next 5Y12.00% ROE5.40% 52W Range18.22 - 28.71 Perf YTD15.43%
Dividend0.48 P/FCF13.35 EPS past 5Y-3.80% ROI12.90% 52W High-2.16% Beta1.21
Dividend %1.71% Quick Ratio4.70 Sales past 5Y0.50% Gross Margin46.90% 52W Low54.17% ATR0.82
Employees2778 Current Ratio5.30 Sales Q/Q11.10% Oper. Margin15.70% RSI (14)74.82 Volatility3.67% 3.09%
OptionableYes Debt/Eq0.02 EPS Q/Q12.50% Profit Margin5.40% Rel Volume0.90 Prev Close28.09
ShortableYes LT Debt/Eq0.02 EarningsMay 10 AMC Payout0.00% Avg Volume830.56K Price28.09
Recom2.20 SMA2013.06% SMA5018.02% SMA20017.23% Volume747,160 Change0.00%
Nov-18-16Downgrade Standpoint Research Buy → Hold
Jul-09-15Initiated Singular Research Buy $16.50
Sep-30-13Initiated Standpoint Research Buy $17
Jan-07-11Upgrade Oppenheimer Underperform → Outperform $5 → $11
Oct-12-10Downgrade Jefferies Buy → Hold $10.20 → $6
Sep-14-10Downgrade Oppenheimer Perform → Underperform $10 → $5
Jul-09-10Initiated DA Davidson Buy $14
Apr-14-10Reiterated Oppenheimer Perform $8 → $10
Aug-19-09Initiated Jefferies & Co Buy $6.20
Dec-03-08Reiterated AmTech Research Buy $8 → $4.25
Aug-07-08Reiterated AmTech Research Buy $10 → $8
Jul-10-08Initiated Banc of America Sec Neutral
Jun-16-08Upgrade AmTech Research Neutral → Buy $10
Apr-08-08Initiated Oppenheimer Outperform $5
Jan-08-08Downgrade AmTech Research Buy → Neutral
Nov-16-07Reiterated AmTech Research Buy $12.75 → $9.60
Sep-05-07Initiated Banc of America Sec Neutral $9.75
Feb-20-07Downgrade Matrix Research Strong Buy → Strong Sell
Feb-05-07Upgrade Am Tech/JSA Research Neutral → Buy
Jul-12-18 07:20AM  Free Technical Research on KLA-Tencor and Three More Semiconductor Equities ACCESSWIRE +6.58%
Jul-11-18 08:30AM  3 Top Growth Stocks to Buy in July Motley Fool
Jul-10-18 02:16PM  July 10th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. (KLIC) GlobeNewswire
11:45AM  FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:19AM  SHAREHOLDER ALERT KLIC PRTA SYMC PPG FLR UNM GOGO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:00AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Kulicke and Soffa Industries, Inc. (KLIC) and Lead Plaintiff Deadline July 10, 2018 GlobeNewswire
09:05AM  Kulicke & Soffa Increases Repurchase Authorization by $100M Business Wire
Jul-09-18 02:57PM  CLASS ACTION UPDATE for KLIC, PRTA, and SYMC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:27AM  Kulicke & Soffa to Participate at SEMICON West 2018 Business Wire
09:05AM  Kulicke & Soffa Launches Katalyst The Next Generation High Accuracy Flip Chip Bonder Business Wire
Jul-08-18 01:00PM  EQUITY ALERT AND NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Kulicke and Soffa Industries, Inc.; July 10 Deadline KLIC Business Wire
Jul-06-18 04:34PM  TUESDAY DEADLINE: The Schall Law Firm Announces it is Investigating Claims Against Kulicke and Soffa Industries, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:12AM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOGO, KLIC, SYMC, HAIR, and FLKS GlobeNewswire
Jul-05-18 05:02PM  DEADLINE IMMINENT: The Schall Law Firm Announces it is Investigating Claims Against Kulicke and Soffa Industries, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
03:44PM  The Law Offices of Howard G. Smith Reminds Investors of July 10th Deadline in the Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. (KLIC) Business Wire
02:55PM  KLIC DEADLINE ALERTS: Pawar Reminds of Important July 10, 2018 Lead Plaintiff Deadline in Class Action - KLIC ACCESSWIRE
12:55PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of INWK, FLEX, KLIC, QCOM, PCG, UNM and COOL GlobeNewswire
08:00AM  IMMINENT DEADLINE: Tuesday is Kulicke & Soffa Shareholders' Last Chance to Apply for Lead Plaintiff Status in Pending Securities Fraud Lawsuit ACCESSWIRE
Jul-04-18 08:15PM  FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Kulicke & Soffa Industries, Inc. (Nasdaq: KLIC) To Contact The Firm GlobeNewswire
08:08AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kulicke and Soffa Industries, Inc. - KLIC ACCESSWIRE
Jul-03-18 04:29PM  July 10th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. (KLIC) Business Wire
02:36PM  7-DAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
01:00PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MOH, KLIC, and SYMC GlobeNewswire
12:57PM  CLASS ACTION UPDATE for INWK, FLEX and KLIC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Jul-02-18 06:42PM  Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
01:03PM  SHAREHOLDER ALERT LC ESPR INWK FLEX KLIC SYMC MFGP FLR REPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:29AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Kulicke and Soffa Industries, Inc. (KLIC) and Lead Plaintiff Deadline - July 10, 2018 ACCESSWIRE
Jun-29-18 07:45PM  SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
07:05AM  Free Research Report as Kulicke and Soffa Industries' Quarterly Earnings Advanced 14.89% ACCESSWIRE
Jun-28-18 04:46PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LC, ESPR, and MFGP GlobeNewswire
02:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kulicke and Soffa Industries, Inc. - KLIC ACCESSWIRE
Jun-27-18 02:52PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KLIC, REPH, ANW, and PCG GlobeNewswire
11:15AM  KLIC NOTICE: Pawar Reminds of Important July 10, 2018 Lead Plaintiff Deadline in Class Action - KLIC ACCESSWIRE
11:00AM  Here's What Cash-Rich Small Caps Do With All Its Liquidity TheStreet.com
11:00AM  2 Cash-Rich Small-Caps to Check Out TheStreet.com
09:05AM  This Small-Cap Semiconductor Stock Now Offers a Solid Dividend Motley Fool
Jun-26-18 06:04PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Kulicke and Soffa Industries, Inc. Investors (KLIC) Business Wire
01:00PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MOH, KLIC, and SYMC GlobeNewswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Kulicke and Soffa Industries, Inc. (KLIC) and Lead Plaintiff Deadline - July 10, 2018 ACCESSWIRE
09:05AM  Kulicke & Soffa to Host Analyst Day on Tuesday - July 10, 2018 Business Wire
Jun-25-18 03:25PM  INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:10PM  INVESTOR ALERT MOH INWK FLEX KLIC TAL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jun-23-18 07:28AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kulicke and Soffa Industries, Inc. - KLIC ACCESSWIRE
Jun-22-18 01:26PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Kulicke and Soffa Industries, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 10, 2018 KLIC GlobeNewswire
09:42AM  What You Must Know About Kulicke and Soffa Industries Incs (NASDAQ:KLIC) 4.87% ROE Simply Wall St.
Jun-21-18 04:21PM  Rosen Law Firm Reminds Kulicke and Soffa Industries, Inc. Investors of Important Deadline in First Filed Class Action - KLIC Business Wire
Jun-20-18 04:30PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Kulicke and Soffa Industries, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 10, 2018 KLIC GlobeNewswire
04:08PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Kulicke and Soffa Industries, Inc. Investors (KLIC) Business Wire
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Kulicke and Soffa Industries, Inc. (KLIC) and Lead Plaintiff Deadline July 10, 2018 GlobeNewswire
Jun-19-18 04:00PM  SHAREHOLDER NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. - KLIC ACCESSWIRE
Jun-18-18 05:13PM  The Klein Law Firm Reminds Investors of Class Actions Commenced on Behalf of Shareholders of Molina Healthcare, Inc., Esperion Therapeutics, Inc., Kulicke and Soffa Industries, Inc., and PPG Industries, Inc. GlobeNewswire
03:51PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Kulicke and Soffa Industries, Inc. (KLIC) and Encourages Investors to Contact the Firm Business Wire
12:39PM  Kulicke and Soffa Deadline: Bernstein Liebhard LLP Reminds Investors of Important Deadline in Securities Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. KLIC GlobeNewswire
Jun-17-18 10:07AM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Actions Involving Flex Ltd., Kulicke and Soffa Industries, Inc., and Symantec Corp. GlobeNewswire
Jun-16-18 08:14AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kulicke and Soffa Industries, Inc. - KLIC ACCESSWIRE
Jun-14-18 08:15PM  DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Kulicke & Soffa Industries, Inc. to Contact the Firm Business Wire
07:05PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Kulicke and Soffa Industries, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 10, 2018 KLIC GlobeNewswire
05:11PM  Kulicke & Soffa Expands Capital Return Program Business Wire
Jun-13-18 08:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kulicke and Soffa Industries, Inc. - KLIC ACCESSWIRE
01:48PM  Kulicke and Soffa Industries, Inc. Reminder: Pawar Law Announces Important July 10, 2018 Lead Plaintiff Deadline in Class Action - KLIC ACCESSWIRE
11:20AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Kulicke and Soffa Industries, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 10, 2018 - KLIC ACCESSWIRE
10:16AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Kulicke and Soffa Industries, Inc. (KLIC) and Lead Plaintiff Deadline - July 10, 2018 ACCESSWIRE
07:05AM  Initiating Free Research Reports on KLA-Tencor and Three Other Semiconductor Equities ACCESSWIRE
Jun-11-18 12:26PM  The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Kulicke and Soffa Industries, Inc. Shareholders and a Lead Plaintiff Deadline of July 10, 2018 Business Wire
09:47AM  KLIC WIRE ALERT: Rosen Law Firm Announces First Filed Securities Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. KLIC GlobeNewswire
Jun-10-18 07:25AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kulicke and Soffa Industries, Inc. - KLIC ACCESSWIRE
Jun-09-18 09:30AM  SHAREHOLDER ALERT: Kaskela Law LLC Reminds Kulicke & Soffa Industries, Inc. Investors of Class Action Lawsuit and Important Deadline Business Wire
Jun-08-18 09:30PM  KLIC TICKER NOTICE: Pawar Reminds of Important July 10, 2018 Lead Plaintiff Deadline in Class Action KLIC ACCESSWIRE
04:00PM  KLIC EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Kulicke and Soffa Industries, Inc. and a Lead Plaintiff Deadline of July 10, 2018 Business Wire
Jun-07-18 04:50PM  INVESTOR DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aceto Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:12PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Kulicke and Soffa Industries, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 10, 2018 Business Wire
10:47AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Kulicke and Soffa Industries, Inc. (KLIC) & Lead Plaintiff Deadline - July 10, 2018 ACCESSWIRE
07:35AM  Detailed Research: Economic Perspectives on Cemex S.A.B. de C.V, Gold Fields, Himax Technologies, Kulicke and Soffa Industries, Just Energy Group, and JD What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jun-06-18 04:30PM  The Klein Law Firm Announces a Class Action Commenced on Behalf of Kulicke and Soffa Industries, Inc. Shareholders and a Lead Plaintiff Deadline of July 10, 2018 Business Wire
03:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kulicke and Soffa Industries, Inc. - KLIC ACCESSWIRE
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Kulicke and Soffa Industries, Inc. (KLIC) & Lead Plaintiff Deadline - July 10, 2018 PR Newswire
Jun-05-18 05:51PM  Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, Mercury Systems, Inc., Ormat Technologies, Inc., and Prothena Corporation PLC PR Newswire
02:07PM  The Klein Law Firm Announces a Class Action Filed on Behalf of Kulicke and Soffa Industries, Inc. Shareholders and a Lead Plaintiff Deadline of July 10, 2018 GlobeNewswire
Jun-04-18 08:15PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Kulicke & Soffa Industries, Inc. (Nasdaq: KLIC) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
03:19PM  Hagens Berman Alerts Investors in Kulicke & Soffa Industries, Inc. (KLIC) to Admitted Improper Accounting and Reminds Investors of the July 10, 2018 Securities Class Action Lead Plaintiff Deadline GlobeNewswire
01:45PM  DEADLINE NOTICE: Kaskela Law LLC Reminds Kulicke & Soffa Industries, Inc. Investors of Important Deadline Business Wire
09:05AM  Kulicke & Soffa to Participate at SMT Hybrid Packaging 2018 Business Wire
Jun-01-18 04:53PM  KLIC INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Kulicke and Soffa Industries, Inc. and a Lead Plaintiff Deadline of July 10, 2018 Business Wire
02:35PM  KLIC EQUITY ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. - KLIC ACCESSWIRE
08:49AM  Kulicke and Soffa Industries (KLIC): Strong Industry, Solid Earnings Estimate Revisions Zacks
May-31-18 04:15PM  KLIC SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Kulicke and Soffa Industries, Inc. and a Lead Plaintiff Deadline of July 10, 2018 GlobeNewswire +5.11%
07:11AM  Kulicke and Soffa: Fiscal 2Q Earnings Snapshot Associated Press
07:00AM  Kulicke & Soffa Finalizes Second Quarter 2018 Results Business Wire
May-30-18 07:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kulicke and Soffa Industries, Inc. - KLIC ACCESSWIRE
May-29-18 02:44PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Kulicke and Soffa Industries, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 10, 2018 Business Wire
09:22AM  INVESTOR ALERT: Kaplan Fox Announces Investigation of Kulicke and Soffa PR Newswire
May-28-18 09:30AM  KLIC LOSS NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Kulicke and Soffa Industries, Inc. - KLIC PR Newswire
May-25-18 08:15PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Kulicke & Soffa Industries, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit Business Wire
02:10PM  KLIC REMINDER: Pawar Announces Deadline in Class Action KLIC ACCESSWIRE
May-22-18 03:27PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Kulicke and Soffa Industries, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 10, 2018 KLIC GlobeNewswire
09:05AM  Kulicke & Soffa Further Extends LED Capabilities Business Wire
07:30AM  KLIC INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Kulicke and Soffa Industries, Inc. Investors Business Wire
May-21-18 01:14PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of Kulicke and Soffa Industries, Inc. Investors (KLIC) Business Wire
May-18-18 08:01PM  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Kulicke & Soffa Industries, Inc. (KLIC) GlobeNewswire
05:00PM  Kulicke & Soffa Alerts Investors to Nasdaq Notification Business Wire
Kulicke and Soffa Industries, Inc. designs, manufactures, and sells capital equipment and expendable tools to assemble semiconductor devices. It operates in two segments, Capital Equipment, and Aftermarket Products and Services (APS). The Capital Equipment segment manufactures and sells a line of ball bonders, wafer level bonders, wedge bonders, advanced packaging, and electronic assembly solutions. The APS segment manufactures and sells various tools for a range of semiconductor packaging applications, which include capillaries, which are expendable tools used in ball bonders; dicing blades that are expendable tools for semiconductor manufacturers to cut silicon wafers into individual semiconductor die or to cut packaged semiconductor units into individual units; and bonding wedges, which are expendable tools used in heavy wire wedge bonders. This segment also provides spare parts, equipment repair, maintenance and servicing, training services, and equipment upgrading services. The company serves semiconductor device manufacturers, integrated device manufacturers, outsourced semiconductor assembly and test providers, other electronics manufacturers, industrial manufacturers, and automotive electronics suppliers primarily in the United States and the Asia/Pacific region. Kulicke and Soffa Industries, Inc. was founded in 1951 and is headquartered in Singapore.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sood DeepakVice PresidentJul 13Sale28.0020,000560,00087,235Jul 17 08:58 AM
BACHMAN BRIAN RDirectorJul 13Sale28.002,20061,60017,928Jul 17 08:56 AM
BACHMAN BRIAN RDirectorJul 10Sale26.003007,80020,128Jul 12 08:45 AM
BACHMAN BRIAN RDirectorJul 02Sale24.004009,60020,428Jul 03 09:34 AM
Milzcik Gregory FDirectorJun 05Buy23.814,18599,63352,807Jun 07 11:02 AM
BACHMAN BRIAN RDirectorApr 13Sale26.003007,80019,500Apr 17 11:12 AM
BACHMAN BRIAN RDirectorApr 02Sale24.884009,95219,800Apr 04 09:42 AM
BACHMAN BRIAN RDirectorMar 21Sale26.003007,80018,871Mar 23 08:59 AM
BACHMAN BRIAN RDirectorJan 02Sale24.474009,78819,171Jan 04 09:02 AM
BACHMAN BRIAN RDirectorNov 16Sale26.2550013,12518,243Nov 20 09:34 AM
Wong Nelson MunPunVice PresidentOct 08Option Exercise0.004,622088,238Oct 10 10:03 AM
Wong Lester ASenior Vice PresidentOct 08Option Exercise0.006,933079,349Oct 10 10:01 AM
Sood DeepakVice PresidentOct 08Option Exercise0.006,9330107,235Oct 10 09:57 AM
Lee IreneSenior Vice PresidentOct 08Option Exercise0.006,933071,846Oct 10 09:53 AM
Chou JonathanExecutive Vice President, CFOOct 08Option Exercise0.0019,6430193,016Oct 10 09:50 AM
Chong Chan PinSenior Vice PresidentOct 08Option Exercise0.001,309035,752Oct 10 09:46 AM
PIERCE GARRETT EDirectorOct 05Sale22.0359213,041120,499Oct 10 08:42 AM
CHEN FUSEN ERNIEPresident and CEOSep 30Option Exercise0.0014,5390152,832Oct 03 01:31 PM
PCRX Pacira Pharmaceuticals, Inc. daily Stock Chart
PCRX [NASD]
Pacira Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.83 Insider Own0.60% Shs Outstand40.71M Perf Week6.96%
Market Cap1.50B Forward P/E37.31 EPS next Y0.99 Insider Trans-16.84% Shs Float40.51M Perf Month-1.99%
Income-33.40M PEG- EPS next Q0.06 Inst Own- Short Float9.91% Perf Quarter3.65%
Sales292.00M P/S5.14 EPS this Y-5.00% Inst Trans1.63% Short Ratio6.24 Perf Half Y-11.08%
Book/sh6.84 P/B5.39 EPS next Y290.91% ROA-5.40% Target Price43.71 Perf Year-25.15%
Cash/sh8.35 P/C4.42 EPS next 5Y62.25% ROE-12.30% 52W Range26.95 - 50.08 Perf YTD-19.17%
Dividend- P/FCF- EPS past 5Y9.10% ROI-5.20% 52W High-26.31% Beta1.74
Dividend %- Quick Ratio7.80 Sales past 5Y49.00% Gross Margin70.50% 52W Low36.92% ATR1.58
Employees489 Current Ratio8.70 Sales Q/Q7.60% Oper. Margin-6.10% RSI (14)60.32 Volatility4.12% 4.61%
OptionableYes Debt/Eq1.01 EPS Q/Q49.80% Profit Margin-11.40% Rel Volume0.66 Prev Close36.65
ShortableYes LT Debt/Eq1.00 EarningsAug 01 BMO Payout- Avg Volume642.77K Price36.90
Recom2.50 SMA207.08% SMA505.47% SMA2001.01% Volume423,305 Change0.68%
Apr-09-18Reiterated H.C. Wainwright Buy $45 → $48
Mar-21-18Reiterated Mizuho Neutral $44 → $31
Feb-16-18Downgrade Needham Buy → Hold
Jan-19-18Initiated Seaport Global Securities Buy $50
Jan-04-18Reiterated Canaccord Genuity Buy $42 → $46
Jan-03-18Initiated Leerink Partners Mkt Perform $46
Dec-18-17Initiated JP Morgan Neutral $47
Nov-29-17Downgrade Mizuho Buy → Neutral $53 → $44
Nov-09-17Resumed H.C. Wainwright Buy $52
Oct-26-17Downgrade Janney Neutral → Sell
Oct-19-17Reiterated Needham Buy $55 → $52
Sep-28-17Initiated Goldman Neutral $41
Sep-07-17Initiated Oppenheimer Perform
Aug-22-17Initiated Needham Buy $55
Aug-21-17Upgrade Janney Sell → Neutral
May-05-17Reiterated Mizuho Buy $57 → $54
Apr-13-17Initiated RBC Capital Mkts Outperform $58
Mar-23-17Reiterated Mizuho Buy $59 → $54
Mar-21-17Reiterated Barclays Overweight $54 → $59
Mar-02-17Reiterated H.C. Wainwright Buy $48 → $59
Jul-16-18 05:25PM  Pacira Focused on Exparel Development Amid Competition Zacks
Jul-11-18 09:37AM  Pacira (PCRX) Issues Strong Preliminary Exparel Sales for Q2 Zacks
Jul-10-18 07:30AM  Pacira Reports Preliminary Net EXPAREL® Sales of $80.4 Million for Second Quarter of 2018 GlobeNewswire
Jul-02-18 07:25AM  Complimentary Technical Snapshots on Mylan and Three More Generic Drugs Stocks ACCESSWIRE
Jun-27-18 11:31AM  Investors Are Undervaluing Pacira Pharmaceuticals Inc (NASDAQ:PCRX) By 43.7% Simply Wall St. -5.27%
Jun-22-18 06:52AM  Heron Therapeutics stock rockets 30% on high hopes for post-surgery pain treatment MarketWatch
Jun-19-18 07:30AM  Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China GlobeNewswire
Jun-18-18 08:20AM  Consolidated Research: 2018 Summary Expectations for Microchip Technology, New Jersey Resources, Brown-Forman, Pacira Pharmaceuticals, Team, and Solaris Oilfield Infrastructure Fundamental Analysis, Key Performance Indications GlobeNewswire
Jun-15-18 07:30AM  Aetna DocFind Directory Now Highlights Providers Offering Opioid Alternatives, Including EXPAREL® GlobeNewswire
Jun-13-18 06:45AM  MEDNAX National Medical Group and Pacira Pharmaceuticals Launch National Enhanced Recovery after Cesarean Surgery (ERACS) Collaborative to Minimize Opioid Use Business Wire
Jun-04-18 05:46AM  Pacira Pharmaceuticals (PCRX) Up 3.5% Since Earnings Report: Can It Continue? Zacks
May-31-18 07:30AM  Pacira Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference GlobeNewswire
May-24-18 07:15AM  Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks ACCESSWIRE
May-07-18 05:15AM  Edited Transcript of PCRX earnings conference call or presentation 3-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-03-18 09:55AM  Pacira: 1Q Earnings Snapshot Associated Press
08:00AM  Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results GlobeNewswire
May-01-18 07:30AM  Pacira Pharmaceuticals to Present at Two Healthcare Conferences in May GlobeNewswire
Apr-26-18 07:30AM  Pacira Pharmaceuticals Announces Timing for First Quarter 2018 Financial Results Webcast and Conference Call GlobeNewswire
Apr-20-18 07:30AM  Detailed Research: Economic Perspectives on PacWest, HD Supply, Limelight Networks, Clean Harbors, Versartis, and Pacira Pharmaceuticals What Drives Growth in Today's Competitive Landscape GlobeNewswire
Apr-13-18 03:20PM  Pharma Stock Roundup: NVS to Buy AveXis, PFE & ABBV's Drugs Succeed in Phase III Zacks
Apr-09-18 05:15PM  FDA Okays Label Expansion of Pacira's Exparel's, Stock Up Zacks
11:24AM  Heres Why The Latest News Is A Big Deal For Pacira Pharmaceuticals Market Exclusive
10:13AM  Company News For Apr 9, 2018 Zacks
08:37AM  Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 12.9% in Session Zacks
Apr-06-18 05:36PM  Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® as a Nerve Block to Produce Regional Analgesia GlobeNewswire +12.88%
04:34PM  Why SUPERVALU, GOL, and Pacira Pharmaceuticals Jumped Today Motley Fool
Apr-02-18 04:58AM  Pacira Pharmaceuticals (PCRX) Down 4.7% Since Earnings Report: Can It Rebound? Zacks -11.72%
Mar-20-18 08:05AM  Pacira Pharmaceuticals, Upcoming PDUFA Date, Analysts Review and Target, FYE Financials ACCESSWIRE
Mar-19-18 05:47PM  Why Heron Therapeutics Stock Soared Today Motley Fool
05:26PM  This Biotech Stock Catapulted After Its Pain Drug Trumped A Key Rival Investor's Business Daily
Mar-09-18 07:00AM  Free Post Earnings Research Report: Lannett's Quarterly Earnings Advanced 15.22% ACCESSWIRE
Mar-06-18 07:30AM  Pacira Pharmaceuticals to Present at the 2018 Barclays Global Healthcare Conference GlobeNewswire
Mar-02-18 02:33PM  Pacira (PCRX) Posts Earnings in Q4, Revenues in Line Zacks
Feb-28-18 10:56PM  Edited Transcript of PCRX earnings conference call or presentation 28-Feb-18 1:30pm GMT Thomson Reuters StreetEvents
10:00AM  Pacira tops Street 4Q forecasts Associated Press
08:00AM  Pacira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update GlobeNewswire
06:40AM  Pacira Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-27-18 07:30AM  University of Tennessee Medical Center at Knoxville, Pacira Pharmaceuticals, and CQ-Insights Announce Collaboration to Minimize Opioid Use After Hernia Surgery GlobeNewswire
Feb-22-18 04:00PM  Pacira Pharmaceuticals Announces Timing for 2017 Financial Results Webcast and Conference Call GlobeNewswire
Feb-20-18 10:41AM  Heres Whats Moving Apricus Biosciences And Pacira Pharmaceuticals Market Exclusive
Feb-16-18 04:15PM  This Biotech Stock May Need Anesthesia After Collapsing Nearly 20% Investor's Business Daily -16.48%
07:30AM  Pacira Pharmaceuticals to Present at the 2018 RBC Capital Markets Healthcare Conference GlobeNewswire
Feb-15-18 05:26PM  FDA Panel Votes 6-4 Against Recommending This Biotech's Pain Blocker Investor's Business Daily
03:34PM  Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia GlobeNewswire
08:15AM  Consolidated Research: 2018 Summary Expectations for Pacira Pharmaceuticals, Wabash National, Spirit Airlines, Praxair, Altice, and Gap Fundamental Analysis, Key Performance Indications GlobeNewswire
Feb-14-18 04:39PM  What You Must Know About Pacira Pharmaceuticals Incs (NASDAQ:PCRX) Financial Strength Simply Wall St.
01:28PM  Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia GlobeNewswire
Feb-12-18 01:29PM  FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia GlobeNewswire
Feb-09-18 08:50AM  Implied Volatility Surging for Pacira (PCRX) Stock Options Zacks
Jan-09-18 08:05AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Jan-08-18 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
07:30AM  WellStar Health System and Pacira Pharmaceuticals Announce Partnership to Minimize Opioid Use and Standardize Outcomes Across Surgical Procedures GlobeNewswire
Jan-05-18 08:02AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Jan-04-18 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit -7.44%
07:30AM  Pacira Pharmaceuticals Reports Preliminary 2017 Revenues of $286.6 Million GlobeNewswire
Jan-03-18 07:30AM  Pacira Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-02-18 08:05AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Dec-28-17 08:02AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Dec-27-17 03:00AM  IBD Rating Upgrades: Pacira Pharmaceuticals Shows Improved Relative Price Strength Investor's Business Daily
Dec-26-17 11:58AM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : December 26, 2017 Capital Cube
Dec-25-17 09:30AM  Pacira Pharmaceuticals, Inc. :PCRX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017 Capital Cube
Dec-14-17 07:30AM  Illinois Surgical Quality Improvement Collaborative and Pacira Pharmaceuticals, Inc. Announce Collaboration to Minimize Opioid Exposure for Postsurgical Patients GlobeNewswire
Dec-13-17 03:00AM  Stocks Showing Improving Market Leadership: Pacira Pharmaceuticals Earns 81 RS Rating Investor's Business Daily
Dec-11-17 02:45AM  Pacira (PCRX) Up 9.3% Since Earnings Report: Can It Continue? Zacks
Dec-08-17 07:30AM  Pacira Pharmaceuticals to Present at the 2017 BMO Capital Markets Prescriptions for Success Healthcare Conference GlobeNewswire
03:00AM  Pacira Pharmaceuticals Sees RS Rating Climb To 75 Investor's Business Daily
Dec-07-17 07:38AM  Pacira Pharmaceuticals names Scott Braunstein COO, Richard Scranton as chief scientific officer MarketWatch
07:30AM  Pacira Announces Promotions of Scott Braunstein, MD, to Chief Operating Officer and Richard Scranton, MD, to Chief Scientific Officer GlobeNewswire
Dec-01-17 08:10AM  Recent Analysis Shows Praxair, Rockwell Automation, Gap, Pacira Pharmaceuticals, Wabash National, and Spirit Airlines Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-29-17 07:00AM  Cancer Treatment Centers of America® Teams with Pacira Pharmaceuticals, Inc. on Innovative Collaboration to Educate Physicians and Patients about Responsible Opioid Use PR Newswire
03:00AM  Stocks Flashing Renewed Technical Strength: Pacira Pharmaceuticals Investor's Business Daily
Nov-27-17 08:05AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Nov-22-17 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Nov-20-17 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Nov-17-17 08:05AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Nov-16-17 07:13AM  Pharma Stock Roundup: FDA Nod for AstraZeneca Severe Asthma Drug, Bayer Signs Deal with Loxo Zacks
Nov-15-17 10:19AM  Pacira's Exparel sNDA to be Reviewed by FDA Advisory Committee Zacks
Nov-14-17 04:21PM  This Biotech Is Feeling The Pain After FDA Sets Panel On Anesthetic Investor's Business Daily -6.61%
07:30AM  Pacira Announces FDA Advisory Committee Meeting to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia GlobeNewswire
Nov-12-17 12:41AM  Edited Transcript of PCRX earnings conference call or presentation 8-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
Nov-09-17 05:00PM  Pacira Pharmaceuticals to Present at Two November Healthcare Conferences GlobeNewswire
Nov-08-17 04:13PM  The Bottom Line on Why Pacira Pharmaceuticals Inc. Rocketed Higher by as Much as 24% Motley Fool +16.98%
07:39AM  Pacira reports 3Q loss Associated Press
07:30AM  Pacira Pharmaceuticals, Inc. Reports Third Quarter 2017 Financial Results Marketwired
Nov-07-17 11:18AM  Pacira Pharmaceuticals, Inc. Value Analysis (NASDAQ:PCRX) : November 7, 2017 Capital Cube
Nov-06-17 12:17PM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : November 6, 2017 Capital Cube
07:17AM  Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PCRX-US : November 6, 2017 Capital Cube
Nov-01-17 08:02AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Oct-31-17 07:30AM  Pacira Pharmaceuticals Announces Timing for Third Quarter 2017 Financial Results Webcast and Conference Call GlobeNewswire
Oct-27-17 08:02AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Oct-25-17 08:00AM  Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement GlobeNewswire
Oct-24-17 09:41AM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : October 24, 2017 Capital Cube
Oct-20-17 07:20AM  Featured Company News - Pacira Announces FDA Acceptance of sNDA for EXPAREL ACCESSWIRE
Oct-19-17 08:04AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Oct-18-17 07:30AM  Pacira Pharmaceuticals Announces FDA Acceptance of sNDA for EXPAREL as a Nerve Block to Produce Regional Analgesia GlobeNewswire
Oct-16-17 09:42AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Oct-13-17 11:08AM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : October 13, 2017 Capital Cube
Oct-06-17 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Oct-02-17 11:01AM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : October 2, 2017 Capital Cube
Sep-29-17 09:05AM  Pacira Pharmaceuticals, Inc. :PCRX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and commercializes proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company's lead product includes, EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STACK DAVID MCEO and ChairmanJun 07Sale36.879,791360,98482,040Jun 08 05:03 PM
STACK DAVID MCEO and ChairmanJun 06Sale35.618,615306,78091,831Jun 08 05:03 PM
Williams Kristen MarieCAO and General CounselJun 04Sale33.022,04067,36119,272Jun 06 08:11 PM
Weiland Robert J.Chief Commercial OfficerJun 04Sale33.0237312,3165,088Jun 06 08:11 PM
Scranton RichardChief Scientific OfficerJun 04Sale33.021,36745,13812,226Jun 06 08:09 PM
Reinhart Charles A. IIIChief Financial OfficerJun 04Sale33.0270823,3788,042Jun 06 08:08 PM
Riker Lauren BullaroVice President, FinanceJun 04Sale33.0280126,4499,641Jun 06 08:09 PM
HASTINGS PAUL JDirectorJun 04Sale33.9077126,1372,747Jun 06 08:07 PM
STACK DAVID MCEO and ChairmanMay 15Option Exercise7.6225,000190,450125,446May 17 07:17 PM
STACK DAVID MCEO and ChairmanMay 15Sale33.7925,000844,781100,446May 17 07:17 PM
STACK DAVID MCEO and ChairmanJan 10Option Exercise1.6128,88546,505129,331Jan 12 06:15 PM
STACK DAVID MCEO and ChairmanJan 10Sale40.1928,8851,160,975100,446Jan 12 06:15 PM
Riker Lauren BullaroVice President, FinanceDec 15Sale43.7034014,85810,442Dec 18 07:52 PM
Jones James BSVP & Chief Medical OfficerNov 20Sale41.1185034,94216,823Nov 20 06:43 PM
Williams Kristen MarieCAO and General CounselNov 17Option Exercise25.377,857199,33229,169Nov 20 06:44 PM
Williams Kristen MarieCAO and General CounselNov 17Sale40.007,857314,28021,312Nov 20 06:44 PM
Williams Kristen MarieCAO and General CounselNov 16Option Exercise25.372,14354,36823,455Nov 20 06:44 PM
Williams Kristen MarieCAO and General CounselNov 16Sale40.012,14385,74121,312Nov 20 06:44 PM
STACK DAVID MCEO and ChairmanNov 15Option Exercise1.6128,88546,505159,164Nov 17 05:15 PM
STACK DAVID MCEO and ChairmanNov 15Sale38.3458,8852,257,708100,279Nov 17 05:15 PM
Kronenfeld Mark A.DirectorNov 10Buy41.601,00041,6036,795Nov 13 08:03 PM
HASTINGS PAUL JDirectorAug 22Sale36.151,04437,7413,518Aug 24 08:30 PM
STACK DAVID MCEO and ChairmanAug 15Option Exercise1.6128,88546,505159,164Aug 17 06:55 PM
Williams Kristen MarieCAO and General CounselAug 15Sale36.753,461127,19221,312Aug 17 06:56 PM
STACK DAVID MCEO and ChairmanAug 15Sale36.3728,8851,050,547130,279Aug 17 06:55 PM
Froimson MarkDirectorAug 08Buy37.131003,713100Aug 16 08:43 PM
STACK DAVID MCEO and ChairmanJul 24Option Exercise1.6115,00024,150130,279Jul 26 05:28 PM